2024 Q2 Form 10-K Financial Statement

#000121390024040080 Filed on May 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2024
Revenue $14.34M $37.23M $56.87M
YoY Change -58.61% 15.22% 61.57%
Cost Of Revenue $22.53M $21.06M $78.18M
YoY Change 33.73% 6.23% 37.67%
Gross Profit $16.15M $16.18M $65.54M
YoY Change -9.2% 29.48% 54.88%
Gross Profit Margin 112.66% 43.44% 115.23%
Selling, General & Admin $1.875M $3.337M $8.618M
YoY Change 2.98% 16.51% 18.64%
% of Gross Profit 11.61% 20.63% 13.15%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $24.34M $3.337M $86.85M
YoY Change 1237.21% 16.51% 35.9%
Operating Profit -$8.194M $12.84M -$21.31M
YoY Change -151.32% 33.33% -1.3%
Interest Expense $30.00K -$7.205M -$46.98M
YoY Change -100.19% -167.78% 504.52%
% of Operating Profit -56.12%
Other Income/Expense, Net -$55.10K $42.18K $81.41K
YoY Change
Pretax Income $6.956M $5.676M $9.908M
YoY Change -3361.77% -71.45% -61.43%
Income Tax -$60.28K $368.8K $42.93K
% Of Pretax Income -0.87% 6.5% 0.43%
Net Earnings $6.610M $5.307M $8.934M
YoY Change -3199.71% -72.36% -63.8%
Net Earnings / Revenue 46.11% 14.25% 15.71%
Basic Earnings Per Share $0.48 $0.71
Diluted Earnings Per Share $0.48 $0.39 $0.71
COMMON SHARES
Basic Shares Outstanding 13.70M shares 13.65M shares 12.67M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2024 Q1 2024
SHORT-TERM ASSETS
Cash & Short-Term Investments $93.30M $40.51M $40.51M
YoY Change 75.52% -57.84% -57.84%
Cash & Equivalents $32.23M $8.693M $40.51M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $94.92M $40.95M $40.95M
YoY Change 77.03% -57.73% -57.73%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $50.69M $91.27M $1.139B
YoY Change -95.32% -21.49% 17.09%
Other Assets $1.686M $1.163M
YoY Change 152.45% 118.92%
Total Long-Term Assets $1.107B $1.150B $1.150B
YoY Change 1.31% 17.22% 17.22%
TOTAL ASSETS
Total Short-Term Assets $94.92M $40.95M $40.95M
Total Long-Term Assets $1.107B $1.150B $1.150B
Total Assets $1.202B $1.191B $1.191B
YoY Change 4.85% 10.49% 10.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.892M $9.485M $9.485M
YoY Change -14.16% -30.15% -30.15%
Accrued Expenses $4.935M $3.582M $3.582M
YoY Change 10.02% -1.94% -1.94%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $15.20M $13.52M $13.52M
YoY Change -7.16% -21.68% -21.68%
LONG-TERM LIABILITIES
Long-Term Debt $831.4M $820.9M $820.9M
YoY Change 2.75% 12.58% 12.58%
Other Long-Term Liabilities -$16.79M -$17.27M -$17.27M
YoY Change -14.18% -4.51% -4.51%
Total Long-Term Liabilities $814.6M $803.7M $803.7M
YoY Change 3.17% 13.01% 13.01%
TOTAL LIABILITIES
Total Short-Term Liabilities $15.20M $13.52M $13.52M
Total Long-Term Liabilities $814.6M $803.7M $803.7M
Total Liabilities $833.9M $821.0M $821.0M
YoY Change 3.11% 12.28% 12.28%
SHAREHOLDERS EQUITY
Retained Earnings -$4.227M -$870.7K
YoY Change -125.4% -103.48%
Common Stock $372.1M $371.1M
YoY Change 15.98% 15.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $367.9M $370.2M $370.2M
YoY Change
Total Liabilities & Shareholders Equity $1.202B $1.191B $1.191B
YoY Change 4.85% 10.49% 10.49%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2024
OPERATING ACTIVITIES
Net Income $6.610M $5.307M $8.934M
YoY Change -3199.71% -72.36% -63.8%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $52.15M -$20.66M -$157.2M
YoY Change -147.01% -163.46% 20.58%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid $8.979M $32.05M
YoY Change 25.86% 41.42%
Common Stock Issuance & Retirement, Net $44.54M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $644.7K 14.14M $101.6M
YoY Change -99.05% -14.17% -41.45%
NET CHANGE
Cash From Operating Activities $52.15M -20.66M -$157.2M
Cash From Investing Activities
Cash From Financing Activities $644.7K 14.14M $101.6M
Net Change In Cash $52.79M -6.519M -$55.57M
YoY Change -222.99% -113.3% -228.61%
FREE CASH FLOW
Cash From Operating Activities $52.15M -$20.66M -$157.2M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024 dei Auditor Firm
AuditorFirmId
42
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024 dei Document Type
DocumentType
10-K
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-02-29
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024 dei Document Transition Report
DocumentTransitionReport
false
CY2024 dei Entity File Number
EntityFileNumber
814-00732
CY2024 dei Entity Registrant Name
EntityRegistrantName
SARATOGA INVESTMENT CORP.
CY2024 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2024 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-8700615
CY2024 dei Entity Address Address Line1
EntityAddressAddressLine1
535 Madison Avenue
CY2024 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2024 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2024 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10022
CY2024 dei City Area Code
CityAreaCode
(212)
CY2024 dei Local Phone Number
LocalPhoneNumber
906-7800
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024 dei Entity Small Business
EntitySmallBusiness
false
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Public Float
EntityPublicFloat
271200000 usd
CY2024 dei Auditor Location
AuditorLocation
New York
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13698966 shares
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2024Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1019774616 usd
CY2023Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
828028800 usd
CY2024Q1 sar Investments In And Advances To Affiliates At Fair Values
InvestmentsInAndAdvancesToAffiliatesAtFairValues
27749137 usd
CY2023Q1 sar Investments In And Advances To Affiliates At Fair Values
InvestmentsInAndAdvancesToAffiliatesAtFairValues
28305871 usd
CY2024Q1 us-gaap Equity Method Investments
EquityMethodInvestments
91270036 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
346958042 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1191205835 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1078158174 usd
CY2024Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
27.12
CY2023Q1 us-gaap Equity Method Investments
EquityMethodInvestments
116255582 usd
CY2024Q1 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1179783737 usd
CY2023Q1 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
966489357 usd
CY2024Q1 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
1138793789 usd
CY2023Q1 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
972590253 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8692846 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
65746494 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
31814278 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
30329779 usd
CY2024Q1 sar Net Reserve Of Interest Receivable
NetReserveOfInterestReceivable
9490340 usd
CY2023Q1 sar Net Reserve Of Interest Receivable
NetReserveOfInterestReceivable
2217300 usd
CY2024Q1 us-gaap Interest Receivable
InterestReceivable
10298998 usd
CY2023Q1 us-gaap Interest Receivable
InterestReceivable
8159951 usd
CY2024Q1 sar Management Fee Receivable
ManagementFeeReceivable
343023 usd
CY2023Q1 sar Management Fee Receivable
ManagementFeeReceivable
363809 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1163225 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
531337 usd
CY2024Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
99676 usd
CY2023Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
436551 usd
CY2024Q1 us-gaap Assets
Assets
1191205835 usd
CY2023Q1 us-gaap Assets
Assets
1078158174 usd
CY2024Q1 us-gaap Line Of Credit
LineOfCredit
35000000 usd
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
32500000 usd
CY2024Q1 sar Base Management And Incentive Fees Payable
BaseManagementAndIncentiveFeesPayable
8147217 usd
CY2023Q1 sar Base Management And Incentive Fees Payable
BaseManagementAndIncentiveFeesPayable
12114878 usd
CY2024Q1 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
3791150 usd
CY2023Q1 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
2816572 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
1337542 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
1464343 usd
CY2024Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
3582173 usd
CY2023Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
3652936 usd
CY2023Q1 sar Directors Fees Payable
DirectorsFeesPayable
14932 usd
CY2024Q1 sar Due To Affiliates Current
DueToAffiliatesCurrent
450000 usd
CY2023Q1 sar Due To Affiliates Current
DueToAffiliatesCurrent
10935 usd
CY2024Q1 us-gaap Liabilities
Liabilities
820981727 usd
CY2023Q1 us-gaap Liabilities
Liabilities
731200132 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13653476 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13653476 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11890500 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11890500 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
13654 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
11891 usd
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
371081199 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
321893806 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-870745 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
25052345 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
370224108 usd
CY2023Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
29.18
CY2024 us-gaap Interest Income Interest Earning Asset
InterestIncomeInterestEarningAsset
113521652 usd
CY2023 us-gaap Interest Income Interest Earning Asset
InterestIncomeInterestEarningAsset
72677237 usd
CY2022 us-gaap Interest Income Interest Earning Asset
InterestIncomeInterestEarningAsset
46369544 usd
CY2024 sar Interest Income On Affiliate Investments
InterestIncomeOnAffiliateInvestments
3299816 usd
CY2023 sar Interest Income On Affiliate Investments
InterestIncomeOnAffiliateInvestments
4773527 usd
CY2022 sar Interest Income On Affiliate Investments
InterestIncomeOnAffiliateInvestments
3308471 usd
CY2024 sar Interest Income On Control Investments
InterestIncomeOnControlInvestments
8507909 usd
CY2023 sar Interest Income On Control Investments
InterestIncomeOnControlInvestments
6602594 usd
CY2022 sar Interest Income On Control Investments
InterestIncomeOnControlInvestments
7345691 usd
CY2024 sar Payment In Kind Interest Income On Non Control And Non Affiliate Investments
PaymentInKindInterestIncomeOnNonControlAndNonAffiliateInvestments
766697 usd
CY2023 sar Payment In Kind Interest Income On Non Control And Non Affiliate Investments
PaymentInKindInterestIncomeOnNonControlAndNonAffiliateInvestments
359910 usd
CY2022 sar Payment In Kind Interest Income On Non Control And Non Affiliate Investments
PaymentInKindInterestIncomeOnNonControlAndNonAffiliateInvestments
1150695 usd
CY2024 sar Payment In Kind Interest Income On Affiliate Investments
PaymentInKindInterestIncomeOnAffiliateInvestments
874226 usd
CY2023 sar Payment In Kind Interest Income On Affiliate Investments
PaymentInKindInterestIncomeOnAffiliateInvestments
416711 usd
CY2024 sar Payment In Kind Interest Income On Control Investments
PaymentInKindInterestIncomeOnControlInvestments
814925 usd
CY2023 sar Payment In Kind Interest Income On Control Investments
PaymentInKindInterestIncomeOnControlInvestments
386889 usd
CY2022 sar Payment In Kind Interest Income On Control Investments
PaymentInKindInterestIncomeOnControlInvestments
327171 usd
CY2024 us-gaap Investment Income Net
InvestmentIncomeNet
127785225 usd
CY2023 us-gaap Investment Income Net
InvestmentIncomeNet
85216868 usd
CY2022 us-gaap Investment Income Net
InvestmentIncomeNet
58501572 usd
CY2024 sar Interest From Cash And Cash Equivalents
InterestFromCashAndCashEquivalents
2512416 usd
CY2023 sar Interest From Cash And Cash Equivalents
InterestFromCashAndCashEquivalents
1368489 usd
CY2022 sar Interest From Cash And Cash Equivalents
InterestFromCashAndCashEquivalents
3584 usd
CY2024 sar Management Fee Income
ManagementFeeIncome
3270232 usd
CY2023 sar Management Fee Income
ManagementFeeIncome
3269820 usd
CY2022 sar Management Fee Income
ManagementFeeIncome
3262591 usd
CY2022 sar Dividend Income On Noncontrol Nonaffiliate Investments
DividendIncomeOnNoncontrolNonaffiliateInvestments
1379182 usd
CY2023 sar Dividend Income On Affiliate Investments
DividendIncomeOnAffiliateInvestments
615917 usd
CY2022 sar Dividend Income On Affiliate Investments
DividendIncomeOnAffiliateInvestments
546609 usd
CY2024 sar Dividend Income On Control Investments
DividendIncomeOnControlInvestments
5911564 usd
CY2024 sar Dividends From Investments
DividendsFromInvestments
6532962 usd
CY2023 sar Dividends From Investments
DividendsFromInvestments
2720272 usd
CY2022 sar Dividends From Investments
DividendsFromInvestments
1925791 usd
CY2024 us-gaap Investment Banking Advisory Brokerage And Underwriting Fees And Commissions
InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions
2149751 usd
CY2023 us-gaap Investment Banking Advisory Brokerage And Underwriting Fees And Commissions
InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions
3585061 usd
CY2022 us-gaap Investment Banking Advisory Brokerage And Underwriting Fees And Commissions
InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions
4307647 usd
CY2024 us-gaap Other Income
OtherIncome
1469320 usd
CY2023 us-gaap Other Income
OtherIncome
2943610 usd
CY2022 us-gaap Other Income
OtherIncome
2739372 usd
CY2024 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
143719906 usd
CY2023 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
99104120 usd
CY2022 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
70740557 usd
CY2024 us-gaap Interest And Debt Expense
InterestAndDebtExpense
49179899 usd
CY2023 us-gaap Interest And Debt Expense
InterestAndDebtExpense
33498489 usd
CY2022 us-gaap Interest And Debt Expense
InterestAndDebtExpense
19880693 usd
CY2024 us-gaap Management Fee Expense
ManagementFeeExpense
19212337 usd
CY2023 us-gaap Management Fee Expense
ManagementFeeExpense
16423960 usd
CY2022 us-gaap Management Fee Expense
ManagementFeeExpense
11901729 usd
CY2024 sar Incentive Management Fees Expense Benefit
IncentiveManagementFeesExpenseBenefit
8025468 usd
CY2023 sar Incentive Management Fees Expense Benefit
IncentiveManagementFeesExpenseBenefit
5057117 usd
CY2022 sar Incentive Management Fees Expense Benefit
IncentiveManagementFeesExpenseBenefit
11794208 usd
CY2024 us-gaap Professional Fees
ProfessionalFees
1767015 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
1812259 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
1378134 usd
CY2024 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
3872917 usd
CY2023 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
3160417 usd
CY2022 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
2906250 usd
CY2024 us-gaap General Insurance Expense
GeneralInsuranceExpense
322323 usd
CY2023 us-gaap General Insurance Expense
GeneralInsuranceExpense
347483 usd
CY2022 us-gaap General Insurance Expense
GeneralInsuranceExpense
348671 usd
CY2024 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
351297 usd
CY2023 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
360000 usd
CY2022 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
335596 usd
CY2024 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2241579 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2328672 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1661932 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
42926 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-152956 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-39649 usd
CY2024 sar Excise Tax Expense
ExciseTaxExpense
1829837 usd
CY2023 sar Excise Tax Expense
ExciseTaxExpense
1067532 usd
CY2022 sar Excise Tax Expense
ExciseTaxExpense
630183 usd
CY2024 us-gaap Operating Expenses
OperatingExpenses
86845598 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
63902973 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
50797747 usd
CY2024 us-gaap Net Investment Income
NetInvestmentIncome
56874308 usd
CY2023 us-gaap Net Investment Income
NetInvestmentIncome
35201147 usd
CY2022 us-gaap Net Investment Income
NetInvestmentIncome
19942810 usd
CY2024 sar Realized Gain Loss From Affiliate Investments
RealizedGainLossFromAffiliateInvestments
153583 usd
CY2023 sar Realized Gain Loss From Affiliate Investments
RealizedGainLossFromAffiliateInvestments
7446596 usd
CY2022 sar Realized Gain Loss From Affiliate Investments
RealizedGainLossFromAffiliateInvestments
6209737 usd
CY2022 sar Affiliate Investments
AffiliateInvestments
7328457 usd
CY2022 sar Realized Gain Loss From Control Investments
RealizedGainLossFromControlInvestments
-139867 usd
CY2024 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
153583 usd
CY2023 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
7446596 usd
CY2022 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
13398327 usd
CY2023 sar Income Tax Provision Benefit From Realized Gain Loss On Investments
IncomeTaxProvisionBenefitFromRealizedGainLossOnInvestments
548568 usd
CY2022 sar Income Tax Provision Benefit From Realized Gain Loss On Investments
IncomeTaxProvisionBenefitFromRealizedGainLossOnInvestments
-2886444 usd
CY2024 sar Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments
UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments
-24167727 usd
CY2023 sar Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments
UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments
-5330880 usd
CY2022 sar Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments
UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments
14775190 usd
CY2024 sar Unrealized Appreciation Depreciation On Affiliate Investments
UnrealizedAppreciationDepreciationOnAffiliateInvestments
-1541829 usd
CY2023 sar Unrealized Appreciation Depreciation On Affiliate Investments
UnrealizedAppreciationDepreciationOnAffiliateInvestments
574354 usd
CY2022 sar Unrealized Appreciation Depreciation On Affiliate Investments
UnrealizedAppreciationDepreciationOnAffiliateInvestments
-26836 usd
CY2024 sar Unrealized Appreciation Depreciation On Control Investments
UnrealizedAppreciationDepreciationOnControlInvestments
-21381288 usd
CY2023 sar Unrealized Appreciation Depreciation On Control Investments
UnrealizedAppreciationDepreciationOnControlInvestments
-10461606 usd
CY2022 sar Unrealized Appreciation Depreciation On Control Investments
UnrealizedAppreciationDepreciationOnControlInvestments
2271639 usd
CY2024 sar Net Change In Unrealized Appreciationdepreciation On Investments
NetChangeInUnrealizedAppreciationdepreciationOnInvestments
-47090844 usd
CY2023 sar Net Change In Unrealized Appreciationdepreciation On Investments
NetChangeInUnrealizedAppreciationdepreciationOnInvestments
-15218132 usd
CY2022 sar Net Change In Unrealized Appreciationdepreciation On Investments
NetChangeInUnrealizedAppreciationdepreciationOnInvestments
17019993 usd
CY2024 sar Net Change In Provision For Deferred Taxes On Unrealizedappreciation Depreciation On Investments
NetChangeInProvisionForDeferredTaxesOnUnrealizedappreciationDepreciationOnInvestments
893166 usd
CY2023 sar Net Change In Provision For Deferred Taxes On Unrealizedappreciation Depreciation On Investments
NetChangeInProvisionForDeferredTaxesOnUnrealizedappreciationDepreciationOnInvestments
1715333 usd
CY2022 sar Net Change In Provision For Deferred Taxes On Unrealizedappreciation Depreciation On Investments
NetChangeInProvisionForDeferredTaxesOnUnrealizedappreciationDepreciationOnInvestments
-694908 usd
CY2024 sar Net Realized And Unrealized Gainloss On Investments
NetRealizedAndUnrealizedGainlossOnInvestments
-47830427 usd
CY2023 sar Net Realized And Unrealized Gainloss On Investments
NetRealizedAndUnrealizedGainlossOnInvestments
-8938301 usd
CY2022 sar Net Realized And Unrealized Gainloss On Investments
NetRealizedAndUnrealizedGainlossOnInvestments
28226784 usd
CY2024 sar Realized Losses On Extinguishment Of Debt
RealizedLossesOnExtinguishmentOfDebt
-110056 usd
CY2023 sar Realized Losses On Extinguishment Of Debt
RealizedLossesOnExtinguishmentOfDebt
-1587083 usd
CY2022 sar Realized Losses On Extinguishment Of Debt
RealizedLossesOnExtinguishmentOfDebt
-2434410 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
8933825 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
24675763 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
45735184 usd
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.71
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.06
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.99
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12670939 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11963533 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11456631 shares
CY2024 us-gaap Net Investment Income
NetInvestmentIncome
56874308 usd
CY2023 us-gaap Net Investment Income
NetInvestmentIncome
35201147 usd
CY2022 us-gaap Net Investment Income
NetInvestmentIncome
19942810 usd
CY2024 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
153583 usd
CY2023 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
7446596 usd
CY2022 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
13398327 usd
CY2024 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-110056 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1587083 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2434410 usd
CY2023 sar Income Tax Provision Benefit From Realized Gain Loss On Investments
IncomeTaxProvisionBenefitFromRealizedGainLossOnInvestments
548568 usd
CY2022 sar Income Tax Provision Benefit From Realized Gain Loss On Investments
IncomeTaxProvisionBenefitFromRealizedGainLossOnInvestments
-2886444 usd
CY2024 sar Net Change In Unrealized Appreciation Depreciation On Investments
NetChangeInUnrealizedAppreciationDepreciationOnInvestments
-47090844 usd
CY2023 sar Net Change In Unrealized Appreciation Depreciation On Investments
NetChangeInUnrealizedAppreciationDepreciationOnInvestments
-15218132 usd
CY2022 sar Net Change In Unrealized Appreciation Depreciation On Investments
NetChangeInUnrealizedAppreciationDepreciationOnInvestments
17019993 usd
CY2024 sar Net Change In Provision For Deferred Taxes On Unrealizedappreciation Depreciation On Investments
NetChangeInProvisionForDeferredTaxesOnUnrealizedappreciationDepreciationOnInvestments
893166 usd
CY2023 sar Net Change In Provision For Deferred Taxes On Unrealizedappreciation Depreciation On Investments
NetChangeInProvisionForDeferredTaxesOnUnrealizedappreciationDepreciationOnInvestments
1715333 usd
CY2022 sar Net Change In Provision For Deferred Taxes On Unrealizedappreciation Depreciation On Investments
NetChangeInProvisionForDeferredTaxesOnUnrealizedappreciationDepreciationOnInvestments
-694908 usd
CY2024 sar Net Increase In Net Assets Resulting From Operations
NetIncreaseInNetAssetsResultingFromOperations
8933825 usd
CY2023 sar Net Increase In Net Assets Resulting From Operations
NetIncreaseInNetAssetsResultingFromOperations
24675763 usd
CY2022 sar Net Increase In Net Assets Resulting From Operations
NetIncreaseInNetAssetsResultingFromOperations
45735184 usd
CY2024 sar Investment Company Distribution To Shareholders
InvestmentCompanyDistributionToShareholders
35635955 usd
CY2023 sar Investment Company Distribution To Shareholders
InvestmentCompanyDistributionToShareholders
27313402 usd
CY2022 sar Investment Company Distribution To Shareholders
InvestmentCompanyDistributionToShareholders
22033235 usd
CY2024 sar Net Decrease In Net Assets From Shareholder Distribution
NetDecreaseInNetAssetsFromShareholderDistribution
-35635955 usd
CY2023 sar Net Decrease In Net Assets From Shareholder Distribution
NetDecreaseInNetAssetsFromShareholderDistribution
-27313402 usd
CY2022 sar Net Decrease In Net Assets From Shareholder Distribution
NetDecreaseInNetAssetsFromShareholderDistribution
-22033235 usd
CY2024 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
44539387 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
26835203 usd
CY2024 sar Stock Issued During Period Capital Contribution From Manager
StockIssuedDuringPeriodCapitalContributionFromManager
4475297 usd
CY2024 sar Investment Company Dividend Distributions
InvestmentCompanyDividendDistributions
3582345 usd
CY2023 sar Investment Company Dividend Distributions
InvestmentCompanyDividendDistributions
4648262 usd
CY2022 sar Investment Company Dividend Distributions
InvestmentCompanyDividendDistributions
3875206 usd
CY2024 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2157605 usd
CY2023 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
10824340 usd
CY2022 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2545037 usd
CY2024 sar Investment Company Capital Share Transactions Repurchase Fees
InvestmentCompanyCapitalShareTransactionsRepurchaseFees
1772 usd
CY2023 sar Investment Company Capital Share Transactions Repurchase Fees
InvestmentCompanyCapitalShareTransactionsRepurchaseFees
8764 usd
CY2022 sar Investment Company Capital Share Transactions Repurchase Fees
InvestmentCompanyCapitalShareTransactionsRepurchaseFees
1992 usd
CY2024 sar Stock Issued During Period Value Offering Cost
StockIssuedDuringPeriodValueOfferingCost
469456 usd
CY2022 sar Stock Issued During Period Value Offering Cost
StockIssuedDuringPeriodValueOfferingCost
270576 usd
CY2024 us-gaap Investment Company Increase Decrease From Share Transaction
InvestmentCompanyIncreaseDecreaseFromShareTransaction
49968196 usd
CY2023 us-gaap Investment Company Increase Decrease From Share Transaction
InvestmentCompanyIncreaseDecreaseFromShareTransaction
-6184842 usd
CY2022 us-gaap Investment Company Increase Decrease From Share Transaction
InvestmentCompanyIncreaseDecreaseFromShareTransaction
27892804 usd
CY2024 sar Investment Company Net Asset Period Increase Decrease
InvestmentCompanyNetAssetPeriodIncreaseDecrease
23266066 usd
CY2023 sar Investment Company Net Asset Period Increase Decrease
InvestmentCompanyNetAssetPeriodIncreaseDecrease
-8822481 usd
CY2022 sar Investment Company Net Asset Period Increase Decrease
InvestmentCompanyNetAssetPeriodIncreaseDecrease
51594753 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
346958042 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
355780523 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
304185770 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
370224108 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
346958042 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
355780523 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
8933825 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
24675763 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
45735184 usd
CY2024 sar Paymentinkind And Other Adjustments To Cost
PaymentinkindAndOtherAdjustmentsToCost
4910320 usd
CY2023 sar Paymentinkind And Other Adjustments To Cost
PaymentinkindAndOtherAdjustmentsToCost
1882734 usd
CY2022 sar Paymentinkind And Other Adjustments To Cost
PaymentinkindAndOtherAdjustmentsToCost
349292 usd
CY2024 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
2221257 usd
CY2023 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1816934 usd
CY2022 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
2043088 usd
CY2024 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
5171249 usd
CY2023 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3587139 usd
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2164761 usd
CY2024 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-110056 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1587083 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2434410 usd
CY2024 sar Income Tax Expensebenefits
IncomeTaxExpensebenefits
42926 usd
CY2023 sar Income Tax Expensebenefits
IncomeTaxExpensebenefits
-152956 usd
CY2022 sar Income Tax Expensebenefits
IncomeTaxExpensebenefits
21260 usd
CY2024 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
153583 usd
CY2023 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
7446596 usd
CY2022 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
13398327 usd
CY2024 sar Net Change In Unrealized Appreciation Depreciation On Investments
NetChangeInUnrealizedAppreciationDepreciationOnInvestments
-47090844 usd
CY2023 sar Net Change In Unrealized Appreciation Depreciation On Investments
NetChangeInUnrealizedAppreciationDepreciationOnInvestments
-15218132 usd
CY2022 sar Net Change In Unrealized Appreciation Depreciation On Investments
NetChangeInUnrealizedAppreciationDepreciationOnInvestments
17019993 usd
CY2024 sar Net Change In Provision For Deferred Taxes On Unrealizedappreciation Depreciation On Investments
NetChangeInProvisionForDeferredTaxesOnUnrealizedappreciationDepreciationOnInvestments
893166 usd
CY2023 sar Net Change In Provision For Deferred Taxes On Unrealizedappreciation Depreciation On Investments
NetChangeInProvisionForDeferredTaxesOnUnrealizedappreciationDepreciationOnInvestments
1715333 usd
CY2022 sar Net Change In Provision For Deferred Taxes On Unrealizedappreciation Depreciation On Investments
NetChangeInProvisionForDeferredTaxesOnUnrealizedappreciationDepreciationOnInvestments
-694908 usd
CY2024 sar Proceeds From Sales And Repayments Of Investments
ProceedsFromSalesAndRepaymentsOfInvestments
30271047 usd
CY2023 sar Proceeds From Sales And Repayments Of Investments
ProceedsFromSalesAndRepaymentsOfInvestments
222215062 usd
CY2022 sar Proceeds From Sales And Repayments Of Investments
ProceedsFromSalesAndRepaymentsOfInvestments
226931104 usd
CY2024 sar Purchases Of Investment
PurchasesOfInvestment
246100906 usd
CY2023 sar Purchases Of Investment
PurchasesOfInvestment
385075296 usd
CY2022 sar Purchases Of Investment
PurchasesOfInvestment
458073629 usd
CY2024 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
2139047 usd
CY2023 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
3066390 usd
CY2022 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
869931 usd
CY2023 us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
-90968 usd
CY2022 us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
-2628032 usd
CY2024 sar Increase Decrease In Management And Incentive Fee Receivable
IncreaseDecreaseInManagementAndIncentiveFeeReceivable
-20786 usd
CY2023 sar Increase Decrease In Management And Incentive Fee Receivable
IncreaseDecreaseInManagementAndIncentiveFeeReceivable
1260 usd
CY2022 sar Increase Decrease In Management And Incentive Fee Receivable
IncreaseDecreaseInManagementAndIncentiveFeeReceivable
327905 usd
CY2024 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
631887 usd
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
276357 usd
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-692335 usd
CY2024 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-336875 usd
CY2023 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
436551 usd
CY2024 sar Increase Decrease In Base Management And Incentive Fees Payable
IncreaseDecreaseInBaseManagementAndIncentiveFeesPayable
3967661 usd
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
101637530 usd
CY2023 sar Increase Decrease In Base Management And Incentive Fees Payable
IncreaseDecreaseInBaseManagementAndIncentiveFeesPayable
832147 usd
CY2022 sar Increase Decrease In Base Management And Incentive Fees Payable
IncreaseDecreaseInBaseManagementAndIncentiveFeesPayable
-6390351 usd
CY2024 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-126801 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
665285 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-951208 usd
CY2023 sar Increase Decrease In Current Tax Payable
IncreaseDecreaseInCurrentTaxPayable
2820036 usd
CY2022 sar Increase Decrease In Current Tax Payable
IncreaseDecreaseInCurrentTaxPayable
-2820036 usd
CY2024 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-70763 usd
CY2023 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
851315 usd
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
155837 usd
CY2024 sar Increase Decrease In Directors Fees Payable
IncreaseDecreaseInDirectorsFeesPayable
14932 usd
CY2023 sar Increase Decrease In Directors Fees Payable
IncreaseDecreaseInDirectorsFeesPayable
55068 usd
CY2022 sar Increase Decrease In Directors Fees Payable
IncreaseDecreaseInDirectorsFeesPayable
500 usd
CY2023 sar Increase Decrease In Excise Tax Payable
IncreaseDecreaseInExciseTaxPayable
630183 usd
CY2022 sar Increase Decrease In Excise Tax Payable
IncreaseDecreaseInExciseTaxPayable
61489 usd
CY2024 sar Increase Decrease In Due To Manager
IncreaseDecreaseInDueToManager
-439065 usd
CY2023 sar Increase Decrease In Due To Manager
IncreaseDecreaseInDueToManager
252879 usd
CY2022 sar Increase Decrease In Due To Manager
IncreaseDecreaseInDueToManager
15251 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-157206679 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-130373839 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-203133627 usd
CY2024 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
71500000 usd
CY2023 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
113000000 usd
CY2022 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
135000000 usd
CY2024 us-gaap Repayments Of Debt
RepaymentsOfDebt
57000000 usd
CY2023 us-gaap Repayments Of Debt
RepaymentsOfDebt
76000000 usd
CY2022 us-gaap Repayments Of Debt
RepaymentsOfDebt
95500000 usd
CY2024 us-gaap Proceeds From Issuance Of Medium Term Notes
ProceedsFromIssuanceOfMediumTermNotes
77500000 usd
CY2023 us-gaap Proceeds From Issuance Of Medium Term Notes
ProceedsFromIssuanceOfMediumTermNotes
223875000 usd
CY2022 us-gaap Proceeds From Issuance Of Medium Term Notes
ProceedsFromIssuanceOfMediumTermNotes
250000000 usd
CY2023 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
43125000 usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
60000000 usd
CY2024 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
4694711 usd
CY2023 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
10135986 usd
CY2022 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
10008424 usd
CY2023 sar Discount On Debt Issuance On Notes
DiscountOnDebtIssuanceOnNotes
-176000 usd
CY2023 sar Discount On Debt Issuance Notes Two Thousand Twenty Five
DiscountOnDebtIssuanceNotesTwoThousandTwentyFive
-360000 usd
CY2022 sar Premium On Debt Issuance
PremiumOnDebtIssuance
1250000 usd
CY2022 sar Discount On Debt Issuance Two Thousand Twenty Seven
DiscountOnDebtIssuanceTwoThousandTwentySeven
-512250 usd
CY2024 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
44539387 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
26835203 usd
CY2024 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
4475297 usd
CY2024 us-gaap Payments Of Dividends
PaymentsOfDividends
32053610 usd
CY2023 us-gaap Payments Of Dividends
PaymentsOfDividends
22665140 usd
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
18158029 usd
CY2024 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
2157605 usd
CY2023 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
10824340 usd
CY2022 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
2545037 usd
CY2024 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1772 usd
CY2023 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-8764 usd
CY2022 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1992 usd
CY2024 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
469456 usd
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
270576 usd
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
5612541 usd
CY2024Q1 sar Total Cash And Cash Equivalents And Cash And Cashs Equivalens Reserve Accounts
TotalCashAndCashEquivalentsAndCashAndCashsEquivalensReserveAccounts
40507124 usd
CY2023Q1 sar Total Cash And Cash Equivalents And Cash And Cashs Equivalens Reserve Accounts
TotalCashAndCashEquivalentsAndCashAndCashsEquivalensReserveAccounts
96076273 usd
CY2022Q1 sar Total Cash And Cash Equivalents And Cash And Cashs Equivalens Reserve Accounts
TotalCashAndCashEquivalentsAndCashAndCashsEquivalensReserveAccounts
52870342 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
173579770 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
226088895 usd
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-55569149 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
43205931 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
22955268 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
96076273 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
52870342 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29915074 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40507124 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
96076273 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
52870342 usd
CY2024 us-gaap Interest Paid Net
InterestPaidNet
44079413 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
28904198 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
17560094 usd
CY2024 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
748721 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2770984 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1355083 usd
CY2024 sar Paymentinkind Interest Income And Other Adjustments To Cost
PaymentinkindInterestIncomeAndOtherAdjustmentsToCost
-4910319 usd
CY2023 sar Paymentinkind Interest Income And Other Adjustments To Cost
PaymentinkindInterestIncomeAndOtherAdjustmentsToCost
-1882734 usd
CY2022 sar Paymentinkind Interest Income And Other Adjustments To Cost
PaymentinkindInterestIncomeAndOtherAdjustmentsToCost
-349292 usd
CY2024 sar Net Accretion Of Discount On Investments
NetAccretionOfDiscountOnInvestments
2221257 usd
CY2023 sar Net Accretion Of Discount On Investments
NetAccretionOfDiscountOnInvestments
1816934 usd
CY2022 sar Net Accretion Of Discount On Investments
NetAccretionOfDiscountOnInvestments
2043088 usd
CY2024 sar Amortization Of Deferred Debt Financing Costs
AmortizationOfDeferredDebtFinancingCosts
5171249 usd
CY2023 sar Amortization Of Deferred Debt Financing Costs
AmortizationOfDeferredDebtFinancingCosts
3587139 usd
CY2022 sar Amortization Of Deferred Debt Financing Costs
AmortizationOfDeferredDebtFinancingCosts
2164761 usd
CY2024 sar Stock Dividend Distribution
StockDividendDistribution
3582345 usd
CY2023 sar Stock Dividend Distribution
StockDividendDistribution
4648262 usd
CY2022 sar Stock Dividend Distribution
StockDividendDistribution
3875206 usd
CY2024Q1 sar Money Market Shares
MoneyMarketShares
40507124 shares
CY2024Q1 us-gaap Investment Owned Restricted Cost
InvestmentOwnedRestrictedCost
40507124 usd
CY2024Q1 us-gaap Financial Instruments Owned Principal Investments At Fair Value
FinancialInstrumentsOwnedPrincipalInvestmentsAtFairValue
40507124 usd
CY2024Q1 sar Investment Owned Percentage
InvestmentOwnedPercentage
0.109 pure
CY2023Q1 sar Money Market Shares
MoneyMarketShares
96076273 shares
CY2023Q1 us-gaap Investment Owned Restricted Cost
InvestmentOwnedRestrictedCost
96076273 usd
CY2023Q1 us-gaap Financial Instruments Owned Principal Investments At Fair Value
FinancialInstrumentsOwnedPrincipalInvestmentsAtFairValue
96076273 usd
CY2023Q1 sar Investment Owned Percentage
InvestmentOwnedPercentage
0.277 pure
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of Estimates in the Preparation of Financial Statements</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The preparation of the accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements, and income, gains (losses) and expenses during the period reported. Actual results could differ materially from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8692846 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
65746494 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47257801 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
31814278 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
30329779 usd
CY2024 us-gaap Revenue Recognition Interest
RevenueRecognitionInterest
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Investment Transactions and Income Recognition</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Purchases and sales of investments and the related realized gains or losses are recorded on a trade-date basis. Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts over the life of the investment and amortization of premiums on investments up to the earliest call date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although management may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection. At February 29, 2024 our investment in three portfolio companies were on non-accrual status with a fair value of approximately $18.9 million, or 1.7% of the fair value of our portfolio. At February 28, 2023, our investment in one portfolio company was on non-accrual status with a fair value of approximately $9.8 million, or 1.0% of the fair value of our portfolio.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Interest income on our investment in the subordinated note of Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325-40, <i>Investments-Other, Beneficial Interests in Securitized Financial Assets</i>, based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.</p>
CY2024Q1 us-gaap Fair Value Option Loans Held As Assets Aggregate Amount In Nonaccrual Status
FairValueOptionLoansHeldAsAssetsAggregateAmountInNonaccrualStatus
18900000 usd
CY2024Q1 sar Fair Value Of Our Portfolio Percentage
FairValueOfOurPortfolioPercentage
0.017 pure
CY2023Q1 us-gaap Fair Value Option Loans Held As Assets Aggregate Amount In Nonaccrual Status
FairValueOptionLoansHeldAsAssetsAggregateAmountInNonaccrualStatus
9800000 usd
CY2023Q1 sar Fair Value Of Our Portfolio Percentage
FairValueOfOurPortfolioPercentage
0.01 pure
CY2024 us-gaap Revenue Recognition Dividends
RevenueRecognitionDividends
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Dividend Income </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Dividend income is recorded in the consolidated statements of operations when earned.</p>
CY2024 sar Minimum Distribute Percent To Qualify Ric
MinimumDistributePercentToQualifyRIC
0.90 pure
CY2024 sar Nondeductible Us Federal Excise Tax
NondeductibleUSFederalExciseTax
0.04 pure
CY2024 sar Minimum Ordinary Income Net Percentage Of Distribute
MinimumOrdinaryIncomeNetPercentageOfDistribute
0.98 pure
CY2024 sar Minimum Capital Gain Income Net Percentage Of Distribute
MinimumCapitalGainIncomeNetPercentageOfDistribute
0.982 pure
CY2024 sar Percentage Of Federal Excise Tax On Income
PercentageOfFederalExciseTaxOnIncome
0.04 pure
CY2024 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
1800000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
1100000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
600000 usd
CY2024 sar Investment Company Dividend Distribution Percentage
InvestmentCompanyDividendDistributionPercentage
0.20 pure
CY2024 sar Investment Company Cash Distribution Percentage
InvestmentCompanyCashDistributionPercentage
0.20 pure
CY2024 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Risk Management</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In the ordinary course of its business, the Company manages a variety of risks, including market and credit risk. Market risk is the risk of potential adverse changes to the value of investments because of changes in market conditions such as interest rate movements and volatility in investment prices.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment’s carrying amount. The Company is also exposed to credit risk related to maintaining all of its cash and cash equivalents, including those in reserve accounts, at a major financial institution and credit risk related to any of its derivative counterparties.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company has investments in lower rated and comparable quality unrated high yield bonds and bank loans. Investments in high yield investments are accompanied by a greater degree of credit risk. The risk of loss due to default by the issuer is significantly greater for holders of high yield securities, because such investments are generally unsecured and are often subordinated to other creditors of the issuer.</p>
CY2024Q1 sar First Lien Term Loans
FirstLienTermLoans
976423 usd
CY2024Q1 sar Second Lien Term Loan
SecondLienTermLoan
18097 usd
CY2024Q1 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
15818 usd
CY2024 sar Fair Valueof Structured Finance Securities
FairValueofStructuredFinanceSecurities
-30626 usd
CY2024Q1 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
97830 usd
CY2024Q1 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
1138794 usd
CY2023Q1 sar First Lien Term Loans
FirstLienTermLoans
798534 usd
CY2023Q1 sar Second Lien Term Loan
SecondLienTermLoan
14936 usd
CY2023Q1 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
20661 usd
CY2023 sar Fair Valueof Structured Finance Securities
FairValueofStructuredFinanceSecurities
-41362 usd
CY2023Q1 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
97097 usd
CY2023Q1 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
972590 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
959483 usd
CY2024 sar Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Adjustments To Cost
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringAdjustmentsToCost
-4910 usd
CY2024 sar Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Accretion Of Discount On Investments
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringAccretionOfDiscountOnInvestments
2221 usd
CY2024 sar Net Change In Unrealized Appreciationdepreciations On Investments
NetChangeInUnrealizedAppreciationdepreciationsOnInvestments
-43388 usd
CY2024 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
246101 usd
CY2024 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
-30271 usd
CY2024 sar Net Realized Gain Loss From Investments
NetRealizedGainLossFromInvestments
154 usd
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1129390 usd
CY2024 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
-40109 usd
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
805551 usd
sar Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Adjustments To Cost
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringAdjustmentsToCost
-1882 usd
sar Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Accretion Of Discount On Investments
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringAccretionOfDiscountOnInvestments
1817 usd
sar Net Change In Unrealized Appreciationdepreciations On Investments
NetChangeInUnrealizedAppreciationdepreciationsOnInvestments
-11851 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
380616 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
-222215 usd
sar Net Realized Gain Loss From Investments
NetRealizedGainLossFromInvestments
7447 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
959483 usd
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
-10254 usd
CY2022 us-gaap Investment Income Dividend
InvestmentIncomeDividend
0 usd
CY2024Q1 sar Fair Value Measurement
FairValueMeasurement
1129390 usd
CY2023Q1 sar Fair Value Measurement
FairValueMeasurement
959483 usd
CY2024Q1 sar Investments At Amortized Cost
InvestmentsAtAmortizedCost
1179784 usd
CY2024Q1 sar Amortized Cost Percentage Of Total Portfolio
AmortizedCostPercentageOfTotalPortfolio
1 pure
CY2024Q1 sar Total Investments At Fair Value
TotalInvestmentsAtFairValue
1138794 usd
CY2024Q1 sar Fair Value Percentage Of Total Portfolio
FairValuePercentageOfTotalPortfolio
1 pure
CY2023Q1 sar Investments At Amortized Cost
InvestmentsAtAmortizedCost
966489 usd
CY2023Q1 sar Amortized Cost Percentage Of Total Portfolio
AmortizedCostPercentageOfTotalPortfolio
1 pure
CY2023Q1 sar Total Investments At Fair Value
TotalInvestmentsAtFairValue
972590 usd
CY2023Q1 sar Fair Value Percentage Of Total Portfolio
FairValuePercentageOfTotalPortfolio
1 pure
CY2024 sar Clo Member Valuation Model Inputs
CLOMemberValuationModelInputs
●Default rate: 2.0%   ● Recovery rate: 35%-70%   ● Discount rate: 8.5%-22.0%   ● Prepayment rate: 20.0%   ● Reinvestment rate / price: S+365bps / $99.00
CY2024 sar Investment Represents Greater Than Five Percent Of Total Assets
InvestmentRepresentsGreaterThanFivePercentOfTotalAssets
0.05 pure
CY2018Q4 sar Legal Maturity Date
LegalMaturityDate
January 2030
CY2021Q1 sar Additional An Invested
AdditionalAnInvested
14000000 usd
CY2021Q1 sar Transaction Of Refinancing And Upsizing Cost Paid
TransactionOfRefinancingAndUpsizingCostPaid
2600000 usd
CY2021Q3 sar Outstanding Receivable
OutstandingReceivable
2600000 usd
CY2024 sar Percentage Owned And Managed
PercentageOwnedAndManaged
1 pure
CY2024 sar Percentage Of Management Fee
PercentageOfManagementFee
0.001 pure
CY2024 sar Percentage Subordinated Management Fee
PercentageSubordinatedManagementFee
0.004 pure
CY2024 sar Percentage Of Excess Cash Flow
PercentageOfExcessCashFlow
0.20 pure
CY2024 sar Percentage Of Internal Rate In Greater
PercentageOfInternalRateInGreater
0.12 pure
CY2024Q1 sar Investments Owned Balance Principal Amount
InvestmentsOwnedBalancePrincipalAmount
8900000 usd
CY2024Q1 sar Investment Principal Balance
InvestmentPrincipalBalance
640800000 usd
CY2024 sar Percentage Of Investments Weighted Average Spread
PercentageOfInvestmentsWeightedAverageSpread
0.038 pure
CY2024 sar Debt Principal Balance
DebtPrincipalBalance
611000000 usd
CY2024 sar Percentage Of Debt Weighted Average Spread
PercentageOfDebtWeightedAverageSpread
0.022 pure
CY2024Q1 sar Cash Flows Of The Subordinated Notes
CashFlowsOfTheSubordinatedNotes
9500000 usd
CY2024Q1 sar Discount Rate Of Subordinated Notes
DiscountRateOfSubordinatedNotes
0.22 pure
CY2023Q1 sar Investment Principal Balance
InvestmentPrincipalBalance
645600000 usd
CY2023 sar Percentage Of Investments Weighted Average Spread
PercentageOfInvestmentsWeightedAverageSpread
0.038 pure
CY2023 sar Debt Principal Balance
DebtPrincipalBalance
611000000 usd
CY2023 sar Percentage Of Debt Weighted Average Spread
PercentageOfDebtWeightedAverageSpread
0.022 pure
CY2023 us-gaap Effect On Future Cash Flows Amount
EffectOnFutureCashFlowsAmount
21200000 usd
CY2023 sar Investement Of Discount Rate
InvestementOfDiscountRate
0.22 pure
CY2024 us-gaap Investment Income Dividend
InvestmentIncomeDividend
5900000 usd
CY2023 us-gaap Investment Income Dividend
InvestmentIncomeDividend
0 usd
CY2024 sar Percentage Of Investment Of Taxable Income
PercentageOfInvestmentOfTaxableIncome
0.90 pure
CY2024Q1 sar Capital In Excess Par Value
CapitalInExcessParValue
779000 usd
CY2023Q1 sar Capital In Excess Par Value
CapitalInExcessParValue
-16000 usd
CY2024Q1 us-gaap Investment Company Distributable Earnings Loss Accumulated Capital Loss Carryforward
InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward
779000 usd
CY2023Q1 us-gaap Investment Company Distributable Earnings Loss Accumulated Capital Loss Carryforward
InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward
-16000 usd
CY2024Q1 us-gaap Investment Company Distributable Earnings Loss Accumulated Ordinary Income Loss
InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss
35636000 usd
CY2023Q1 us-gaap Investment Company Distributable Earnings Loss Accumulated Ordinary Income Loss
InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss
27313000 usd
CY2022Q1 us-gaap Investment Company Distributable Earnings Loss Accumulated Ordinary Income Loss
InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss
22033000 usd
CY2024Q1 sar Investment Company Distributable Earning
InvestmentCompanyDistributableEarning
35636000 usd
CY2023Q1 sar Investment Company Distributable Earning
InvestmentCompanyDistributableEarning
27313000 usd
CY2022Q1 sar Investment Company Distributable Earning
InvestmentCompanyDistributableEarning
22033000 usd
CY2024Q1 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
39700000 usd
CY2024Q1 us-gaap Tax Basis Of Investments Cost For Income Tax Purposes
TaxBasisOfInvestmentsCostForIncomeTaxPurposes
1800000000 usd
CY2023Q1 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
15500000 usd
CY2023Q1 us-gaap Tax Basis Of Investments Cost For Income Tax Purposes
TaxBasisOfInvestmentsCostForIncomeTaxPurposes
1600000000 usd
CY2024 sar Accumulated Capital Losse
AccumulatedCapitalLosse
19900000 usd
CY2023 sar Accumulated Capital Losse
AccumulatedCapitalLosse
1580000 usd
CY2024 sar Other Temporary Differences
OtherTemporaryDifferences
6855000 usd
CY2023 sar Other Temporary Differences
OtherTemporaryDifferences
1971000 usd
CY2024 us-gaap Undistributed Earnings Loss From Continuing Operations Available To Common Shareholders Basic
UndistributedEarningsLossFromContinuingOperationsAvailableToCommonShareholdersBasic
-46215000 usd
CY2023 us-gaap Undistributed Earnings Loss From Continuing Operations Available To Common Shareholders Basic
UndistributedEarningsLossFromContinuingOperationsAvailableToCommonShareholdersBasic
-19771000 usd
CY2024 sar Investment Company Deferred Income Taxes Unrealized Appreciation
InvestmentCompanyDeferredIncomeTaxesUnrealizedAppreciation
-39685000 usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
99582 usd
CY2023 sar Investment Company Deferred Income Taxes Unrealized Appreciation
InvestmentCompanyDeferredIncomeTaxesUnrealizedAppreciation
-15500000 usd
CY2024 sar Components Of Accumulated Losses
ComponentsOfAccumulatedLosses
-6515000 usd
CY2023 sar Components Of Accumulated Losses
ComponentsOfAccumulatedLosses
4662000 usd
CY2024 sar Short Term Capital Loss
ShortTermCapitalLoss
0 usd
CY2024 sar Longterm Capital Loss
LongtermCapitalLoss
19900000 usd
CY2023 sar Net Longterm Capital Losses
NetLongtermCapitalLosses
1600000 usd
CY2024 sar Effective Income Tax Rate Reconciliation At Federal Excise Tax Rate Percent
EffectiveIncomeTaxRateReconciliationAtFederalExciseTaxRatePercent
0.04 pure
CY2024 sar Percentage Of Ordinary Income
PercentageOfOrdinaryIncome
0.98 pure
CY2023 sar Percentage Of Ordinary Income
PercentageOfOrdinaryIncome
0.98 pure
CY2024 sar Percentage Of Capital Gains
PercentageOfCapitalGains
0.982 pure
CY2023 sar Percentage Of Capital Gains
PercentageOfCapitalGains
0.982 pure
CY2024 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
1800000 usd
CY2023 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
1100000 usd
CY2024 sar Owned Percentage
OwnedPercentage
1 pure
CY2024 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.21 pure
CY2024Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2650580 usd
CY2023Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2542373 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
3901995 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
3008829 usd
CY2024Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2539735 usd
CY2023Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2350116 usd
CY2024Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
3791150 usd
CY2023Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
2816572 usd
CY2024Q1 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2500000 usd
CY2024 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
900000 usd
CY2024 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
40000.00 usd
CY2023 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
1700000 usd
CY2023 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
200000 usd
CY2022 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
-700000 usd
CY2022 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
0 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-473475 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
2498515 usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-80273 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
327021 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-553748 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2825536 usd
CY2024 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
990920 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
1467975 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-444628 usd
CY2024 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-16343 usd
CY2024Q1 us-gaap Fair Value Option Ineligible Items Aggregate Carrying Amount
FairValueOptionIneligibleItemsAggregateCarryingAmount
5000000 usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-227737 usd
CY2024 sar Net Deferred Expense
NetDeferredExpense
974577 usd
CY2023 sar Net Deferred Expense
NetDeferredExpense
1567557 usd
CY2022 sar Net Deferred Expense
NetDeferredExpense
-672365 usd
CY2024 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
974577 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1013809 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2153171 usd
CY2024Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
30000.00 usd
CY2024Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
6200000 usd
CY2024Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
2.5 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024 sar Management Agreement
ManagementAgreement
P2Y
CY2024 us-gaap Management Fee Description
ManagementFeeDescription
The base management fee of 1.75% per year is calculated based on the average value of our gross assets (other than cash or cash equivalents, but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters.
CY2024 sar Net Investment Incomes
NetInvestmentIncomes
0.20 pure
CY2024 sar Quarterly Hurdle Rate Measured
QuarterlyHurdleRateMeasured
0.01875 pure
CY2024 us-gaap Incentive Fee Description
IncentiveFeeDescription
Under this provision, in any fiscal quarter, the Manager receives no incentive fee unless our pre-incentive fee net investment income exceeds the hurdle rate of 1.875%. The Manager will receive 100% of pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than or equal to 2.344% in any fiscal quarter; and 20% of the amount of our pre-incentive fee net investment income, if any, that exceeds 2.344% in any fiscal quarter.
CY2010Q2 us-gaap Investment Company Incentive Fee To Average Net Assets
InvestmentCompanyIncentiveFeeToAverageNetAssets
0.20 pure
CY2024 us-gaap Payment For Management Fee
PaymentForManagementFee
19200000 usd
CY2023 us-gaap Payment For Management Fee
PaymentForManagementFee
16400000 usd
CY2022 us-gaap Payment For Management Fee
PaymentForManagementFee
11900000 usd
CY2024 us-gaap Incentive Fee Expense
IncentiveFeeExpense
13000000 usd
CY2023 us-gaap Incentive Fee Expense
IncentiveFeeExpense
6800000 usd
CY2022 us-gaap Incentive Fee Expense
IncentiveFeeExpense
6400000 usd
CY2024 us-gaap Increase Decrease In Management And Incentive Fees Payable
IncreaseDecreaseInManagementAndIncentiveFeesPayable
-8300000 usd
CY2023 us-gaap Increase Decrease In Management And Incentive Fees Payable
IncreaseDecreaseInManagementAndIncentiveFeesPayable
1800000 usd
CY2022 us-gaap Increase Decrease In Management And Incentive Fees Payable
IncreaseDecreaseInManagementAndIncentiveFeesPayable
5500000 usd
CY2024 sar Reimbursement Of Expenses
ReimbursementOfExpenses
3900000 usd
CY2024 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
500000 usd
CY2023 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
1000.000 usd
CY2018Q4 us-gaap Equity Method Investments
EquityMethodInvestments
500000000 usd
CY2024Q1 sar Investment Fair Value
InvestmentFairValue
9500000 usd
CY2023Q1 sar Investment Fair Value
InvestmentFairValue
21200000 usd
CY2022Q4 sar Percentage Of Voting Interest
PercentageOfVotingInterest
0.50 pure
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
402100000 usd
CY2024 us-gaap Interest Income Other
InterestIncomeOther
400000 usd
CY2024 sar Purchased Of Fair Value Percentage
PurchasedOfFairValuePercentage
0.875 pure
CY2024 sar Employ Leverage
EmployLeverage
2 pure
CY2024 sar Asset Coverage Ratio
AssetCoverageRatio
1.611 pure
CY2023 sar Asset Coverage Ratio
AssetCoverageRatio
1.659 pure
CY2024Q1 us-gaap Investment Interest Rate
InvestmentInterestRate
0.25 pure
CY2024Q1 us-gaap Other Borrowings
OtherBorrowings
350000000 usd
CY2024 us-gaap Long Term Debt Weighted Average Interest Rate Over Time
LongTermDebtWeightedAverageInterestRateOverTime
0.0308 pure
CY2023 us-gaap Long Term Debt Weighted Average Interest Rate Over Time
LongTermDebtWeightedAverageInterestRateOverTime
0.0278 pure
CY2022 us-gaap Long Term Debt Weighted Average Interest Rate Over Time
LongTermDebtWeightedAverageInterestRateOverTime
0.026 pure
CY2021Q3 sar Aggregate Principal Amount Percentage
AggregatePrincipalAmountPercentage
0.0625 pure
CY2024Q1 sar Aggregate Principal Amount Percentage
AggregatePrincipalAmountPercentage
0.0725 pure
CY2023Q1 sar Aggregate Principal Amount Percentage
AggregatePrincipalAmountPercentage
0.0725 pure
CY2022Q1 us-gaap Interest Costs Incurred
InterestCostsIncurred
300000 usd
CY2022Q4 us-gaap Interest Costs Incurred
InterestCostsIncurred
200000 usd
CY2023Q1 us-gaap Assets Under Management Carrying Amount
AssetsUnderManagementCarryingAmount
175000000 usd
CY2022Q1 sar Incurred Offering Costs
IncurredOfferingCosts
300000 usd
CY2024Q1 us-gaap Line Of Credit Facility Fair Value Of Amount Outstanding
LineOfCreditFacilityFairValueOfAmountOutstanding
67800000 usd
CY2022Q4 sar Incurred Offering Costs
IncurredOfferingCosts
200000 usd
CY2024 sar Aggregate Amount Indebtedness
AggregateAmountIndebtedness
1000 usd
CY2019Q4 sar Debt Instrument Redemption Amount
DebtInstrumentRedemptionAmount
50000000 usd
CY2020Q1 sar Debt Instrument Redemption Amount
DebtInstrumentRedemptionAmount
24450000 usd
CY2021Q3 sar Debt Instrument Redemption Amount
DebtInstrumentRedemptionAmount
60000000 usd
CY2021Q3 us-gaap Debt Instrument Redemption Price Percentage
DebtInstrumentRedemptionPricePercentage
0.04375 pure
CY2022Q3 sar Debt Instrument Redemption Amount
DebtInstrumentRedemptionAmount
43100000 usd
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
820375 usd
CY2024Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
132400000 usd
CY2023Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
108800000 usd
CY2024Q1 sar Off Balance Sheet Arrangements
OffBalanceSheetArrangements
132429000 usd
CY2023Q1 sar Off Balance Sheet Arrangements
OffBalanceSheetArrangements
108771000 usd
CY2024Q1 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
8700000 usd
CY2024 sar Directors Annual Fee
DirectorsAnnualFee
70000 usd
CY2024 sar Board Meeting Attending Fee
BoardMeetingAttendingFee
3000 usd
CY2024 sar Committee Meeting Attending Fee
CommitteeMeetingAttendingFee
1500 usd
CY2024 sar Audit Committee Annual Fee
AuditCommitteeAnnualFee
12500 usd
CY2024 sar Chairman Annual Fee
ChairmanAnnualFee
6000 usd
CY2024 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
400000 usd
CY2023 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
400000 usd
CY2022 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
300000 usd
CY2024Q1 sar Directors Fee Payable
DirectorsFeePayable
0 usd
CY2023Q1 sar Directors Fee Payable
DirectorsFeePayable
10000.00 usd
CY2018Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1150000 shares
CY2018Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
25
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q3 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
28750000 usd
CY2018Q3 sar Underwriting Commissions
UnderwritingCommissions
1150000 usd
CY2018Q3 sar Offering Cost
OfferingCost
200000 usd
CY2018Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
27400000 usd
CY2018Q3 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
172500 shares
CY2017Q1 sar Offer For Sale
OfferForSale
30000000 usd
CY2019Q3 sar Amount Of Common Stock
AmountOfCommonStock
70000000 usd
CY2019Q4 sar Amount Of Common Stock
AmountOfCommonStock
130000000 usd
CY2021Q3 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
3922018 shares
CY2021Q3 sar Gross Proceeds From Issuance Of Common Stock
GrossProceedsFromIssuanceOfCommonStock
97100000 usd
CY2021Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
24.77
CY2021Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
95900000 usd
CY2021Q3 sar Offer For Sale
OfferForSale
150000000 usd
CY2024Q1 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
1400000 usd
CY2024 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
4500000 usd
CY2022Q1 sar Net Assets
NetAssets
355780523 usd
CY2022Q2 sar Net Investments Income
NetInvestmentsIncome
7976222 usd
CY2022Q2 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
162509 usd
CY2022Q2 sar Income Tax Provision Benefit From Realized Gain Loss On Investments
IncomeTaxProvisionBenefitFromRealizedGainLossOnInvestments
69250 usd
CY2022Q2 sar Net Change In Unrealized Appreciationdepreciation On Investment
NetChangeInUnrealizedAppreciationdepreciationOnInvestment
-9333449 usd
CY2022Q2 sar Net Change In Provision For Deferred Taxes On Unrealized Appreciation Depreciation On Investments
NetChangeInProvisionForDeferredTaxesOnUnrealizedAppreciationDepreciationOnInvestments
-361951 usd
CY2022Q2 sar Distributions Of Investment Income Net
DistributionsOfInvestmentIncomeNet
-6428817 usd
CY2022Q2 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
1108680 usd
CY2022Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
3734316 usd
CY2022Q2 sar Repurchase Fees
RepurchaseFees
-2840 usd
CY2022Q2 sar Net Assets
NetAssets
345235811 usd
CY2022Q3 sar Net Investments Income
NetInvestmentsIncome
7698014 usd
CY2022Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
7943838 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1204809 usd
CY2022Q3 sar Net Change In Unrealized Appreciationdepreciation On Investment
NetChangeInUnrealizedAppreciationdepreciationOnInvestment
-13258456 usd
CY2022Q3 sar Net Change In Provision For Deferred Taxes On Unrealized Appreciation Depreciation On Investments
NetChangeInProvisionForDeferredTaxesOnUnrealizedAppreciationDepreciationOnInvestments
-230154 usd
CY2022Q3 sar Distributions Of Investment Income Net
DistributionsOfInvestmentIncomeNet
-6369981 usd
CY2022Q3 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
1088188 usd
CY2022Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
3686105 usd
CY2022Q3 sar Repurchase Fees
RepurchaseFees
-3071 usd
CY2022Q3 sar Net Assets
NetAssets
337213275 usd
CY2022Q4 sar Net Investments Income
NetInvestmentsIncome
9877437 usd
CY2022Q4 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-740434 usd
CY2022Q4 sar Income Tax Provision Benefit From Realized Gain Loss On Investments
IncomeTaxProvisionBenefitFromRealizedGainLossOnInvestments
479318 usd
CY2022Q4 sar Net Change In Unrealized Appreciationdepreciation On Investment
NetChangeInUnrealizedAppreciationdepreciationOnInvestment
-3176208 usd
CY2022Q4 sar Net Change In Provision For Deferred Taxes On Unrealized Appreciation Depreciation On Investments
NetChangeInProvisionForDeferredTaxesOnUnrealizedAppreciationDepreciationOnInvestments
-425848 usd
CY2022Q4 sar Distributions Of Investment Income Net
DistributionsOfInvestmentIncomeNet
-6433298 usd
CY2022Q4 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
1150934 usd
CY2022Q4 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
2179695 usd
CY2022Q4 sar Repurchase Fees
RepurchaseFees
-1881 usd
CY2022Q4 sar Net Assets
NetAssets
335763600 usd
CY2023Q1 sar Net Investments Income
NetInvestmentsIncome
9649474 usd
CY2023Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
80683 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-382274 usd
CY2023Q1 sar Net Change In Unrealized Appreciationdepreciation On Investment
NetChangeInUnrealizedAppreciationdepreciationOnInvestment
10549981 usd
CY2023Q1 sar Net Change In Provision For Deferred Taxes On Unrealized Appreciation Depreciation On Investments
NetChangeInProvisionForDeferredTaxesOnUnrealizedAppreciationDepreciationOnInvestments
-697380 usd
CY2023Q1 sar Distributions Of Investment Income Net
DistributionsOfInvestmentIncomeNet
-8081306 usd
CY2023Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
1300460 usd
CY2023Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
1224224 usd
CY2023Q1 sar Repurchase Fees
RepurchaseFees
-972 usd
CY2023Q1 sar Net Assets
NetAssets
346958042 usd
CY2023Q2 sar Net Investments Income
NetInvestmentsIncome
15958950 usd
CY2023Q2 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
90691 usd
CY2023Q2 sar Net Change In Unrealized Appreciationdepreciation On Investment
NetChangeInUnrealizedAppreciationdepreciationOnInvestment
-16322307 usd
CY2023Q2 sar Net Change In Provision For Deferred Taxes On Unrealized Appreciation Depreciation On Investments
NetChangeInProvisionForDeferredTaxesOnUnrealizedAppreciationDepreciationOnInvestments
59407 usd
CY2023Q2 sar Distributions Of Investment Income Net
DistributionsOfInvestmentIncomeNet
-8193402 usd
CY2023Q2 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
1058844 usd
CY2023Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
2157605 usd
CY2023Q2 sar Repurchase Fees
RepurchaseFees
-1772 usd
CY2023Q2 sar Net Assets
NetAssets
337450848 usd
CY2023Q3 sar Net Investments Income
NetInvestmentsIncome
13964784 usd
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-110056 usd
CY2023Q3 sar Net Change In Unrealized Appreciationdepreciation On Investment
NetChangeInUnrealizedAppreciationdepreciationOnInvestment
-5737571 usd
CY2023Q3 sar Net Change In Provision For Deferred Taxes On Unrealized Appreciation Depreciation On Investments
NetChangeInProvisionForDeferredTaxesOnUnrealizedAppreciationDepreciationOnInvestments
-221206 usd
CY2023Q3 sar Distributions Of Investment Income Net
DistributionsOfInvestmentIncomeNet
-8352335 usd
CY2023Q3 sar Proceeds From Issuances Of Common Stock
ProceedsFromIssuancesOfCommonStock
22498117 usd
CY2023Q3 us-gaap Partners Capital Account Contributions
PartnersCapitalAccountContributions
2050288 usd
CY2023Q3 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
749313 usd
CY2023Q3 sar Stock Issued During Period Value Offering Cost
StockIssuedDuringPeriodValueOfferingCost
213427 usd
CY2023Q3 sar Net Assets
NetAssets
362078755 usd
CY2023Q4 sar Net Investments Income
NetInvestmentsIncome
14166063 usd
CY2023Q4 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
60565 usd
CY2023Q4 sar Net Change In Unrealized Appreciationdepreciation On Investment
NetChangeInUnrealizedAppreciationdepreciationOnInvestment
-17866353 usd
CY2023Q4 sar Net Change In Provision For Deferred Taxes On Unrealized Appreciation Depreciation On Investments
NetChangeInProvisionForDeferredTaxesOnUnrealizedAppreciationDepreciationOnInvestments
-415894 usd
CY2023Q4 sar Distributions Of Investment Income Net
DistributionsOfInvestmentIncomeNet
-9286642 usd
CY2023Q4 sar Proceeds From Issuances Of Common Stock
ProceedsFromIssuancesOfCommonStock
9012500 usd
CY2023Q4 us-gaap Partners Capital Account Contributions
PartnersCapitalAccountContributions
1043000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
858995 usd
CY2023Q4 sar Stock Issued During Period Value Offering Cost
StockIssuedDuringPeriodValueOfferingCost
92240 usd
CY2023Q4 sar Net Assets
NetAssets
359558749 usd
CY2024Q1 sar Net Investments Income
NetInvestmentsIncome
12784511 usd
CY2024Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
2328 usd
CY2024Q1 sar Net Change In Unrealized Appreciationdepreciation On Investment
NetChangeInUnrealizedAppreciationdepreciationOnInvestment
-7164613 usd
CY2024Q1 sar Net Change In Provision For Deferred Taxes On Unrealized Appreciation Depreciation On Investments
NetChangeInProvisionForDeferredTaxesOnUnrealizedAppreciationDepreciationOnInvestments
-315473 usd
CY2024Q1 sar Distributions Of Investment Income Net
DistributionsOfInvestmentIncomeNet
-9803576 usd
CY2024Q1 sar Proceeds From Issuances Of Common Stock
ProceedsFromIssuancesOfCommonStock
13028770 usd
CY2024Q1 us-gaap Partners Capital Account Contributions
PartnersCapitalAccountContributions
1382009 usd
CY2024Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
915193 usd
CY2024Q1 sar Stock Issued During Period Value Offering Cost
StockIssuedDuringPeriodValueOfferingCost
163789 usd
CY2024Q1 sar Net Assets
NetAssets
370224108 usd
CY2022Q3 sar Stock Issued For Dividend
StockIssuedForDividend
52312 shares
CY2022Q3 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.004 pure
CY2022Q3 sar Stock Based Share Price
StockBasedSharePrice
22
CY2022Q3 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2022Q2 us-gaap Dividends Cash
DividendsCash
5100000 usd
CY2022Q2 sar Stock Issued For Dividend
StockIssuedForDividend
48590 shares
CY2022Q2 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.004 pure
CY2022Q2 sar Stock Based Share Price
StockBasedSharePrice
22.4
CY2022Q2 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2024 sar Investment Company Net Asset From Operations Increase Decrease
InvestmentCompanyNetAssetFromOperationsIncreaseDecrease
8934000 usd
CY2023 sar Investment Company Net Asset From Operations Increase Decrease
InvestmentCompanyNetAssetFromOperationsIncreaseDecrease
24676000 usd
CY2022 sar Investment Company Net Asset From Operations Increase Decrease
InvestmentCompanyNetAssetFromOperationsIncreaseDecrease
45735000 usd
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12670939 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11963533 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11456631 shares
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.71
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.06
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.99
CY2024 sar Distribution Percentage
DistributionPercentage
0.90 pure
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
2.82
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
2.28
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
1.92
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
1.03
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
2.21
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
2.06
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
1.9
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
1.93
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
2.36
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0.4
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
2.65
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
4.25
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
3
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
4.4
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
18.25
CY2023Q1 us-gaap Dividends Cash
DividendsCash
7100000 usd
CY2023Q1 sar Stock Issued For Dividend
StockIssuedForDividend
45818 shares
CY2023Q1 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.004 pure
CY2023Q1 sar Stock Based Share Price
StockBasedSharePrice
23.11
CY2023Q1 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2023Q1 us-gaap Dividends Cash
DividendsCash
6800000 usd
CY2023Q1 sar Stock Issued For Dividend
StockIssuedForDividend
53615 shares
CY2023Q1 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.005 pure
CY2023Q1 sar Stock Based Share Price
StockBasedSharePrice
24.26
CY2023Q1 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2022Q3 us-gaap Dividends Cash
DividendsCash
5300000 usd
CY2022Q1 us-gaap Dividends Cash
DividendsCash
5300000 usd
CY2022Q1 sar Stock Issued For Dividend
StockIssuedForDividend
42825 shares
CY2022Q1 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.004 pure
CY2022Q1 sar Stock Based Share Price
StockBasedSharePrice
25.89
CY2022Q1 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2022Q1 us-gaap Dividends Cash
DividendsCash
5300000 usd
CY2022Q1 sar Stock Issued For Dividend
StockIssuedForDividend
41520 shares
CY2022Q1 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.003 pure
CY2022Q1 sar Stock Based Share Price
StockBasedSharePrice
26.85
CY2022Q1 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2021Q3 us-gaap Dividends Cash
DividendsCash
4900000 usd
CY2021Q3 sar Stock Issued For Dividend
StockIssuedForDividend
38016 shares
CY2021Q3 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.003 pure
CY2021Q3 sar Stock Based Share Price
StockBasedSharePrice
26.77
CY2021Q3 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2021Q2 us-gaap Dividends Cash
DividendsCash
4100000 usd
CY2021Q2 sar Stock Issued For Dividend
StockIssuedForDividend
33100 shares
CY2021Q2 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.003 pure
CY2021Q2 sar Stock Based Share Price
StockBasedSharePrice
25.03
CY2021Q2 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2021Q2 us-gaap Dividends Cash
DividendsCash
3900000 usd
CY2021Q2 sar Stock Issued For Dividend
StockIssuedForDividend
38580 shares
CY2021Q2 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.003 pure
CY2021Q2 sar Stock Based Share Price
StockBasedSharePrice
23.69
CY2021Q2 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2021Q1 us-gaap Dividends Cash
DividendsCash
3800000 usd
CY2021Q1 sar Stock Issued For Dividend
StockIssuedForDividend
41388 shares
CY2021Q1 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.004 pure
CY2021Q1 sar Stock Based Share Price
StockBasedSharePrice
21.75
CY2021Q1 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2020Q4 us-gaap Dividends Cash
DividendsCash
3800000 usd
CY2020Q4 sar Stock Issued For Dividend
StockIssuedForDividend
45706 shares
CY2020Q4 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.004 pure
CY2020Q4 sar Stock Based Share Price
StockBasedSharePrice
17.63
CY2020Q4 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2020Q3 us-gaap Dividends Cash
DividendsCash
3700000 usd
CY2020Q3 sar Stock Issued For Dividend
StockIssuedForDividend
47098 shares
CY2020Q3 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.004 pure
CY2020Q3 sar Stock Based Share Price
StockBasedSharePrice
16.45
CY2020Q3 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2020Q1 us-gaap Dividends Cash
DividendsCash
5400000 usd
CY2020Q1 sar Stock Issued For Dividend
StockIssuedForDividend
35682 shares
CY2020Q1 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.003 pure
CY2020Q1 sar Stock Based Share Price
StockBasedSharePrice
25.44
CY2020Q1 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2019Q3 us-gaap Dividends Cash
DividendsCash
4500000 usd
CY2019Q3 sar Stock Issued For Dividend
StockIssuedForDividend
34575 shares
CY2019Q3 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.004 pure
CY2019Q3 sar Stock Based Share Price
StockBasedSharePrice
23.34
CY2019Q3 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2019Q2 us-gaap Dividends Cash
DividendsCash
3600000 usd
CY2019Q2 sar Stock Issued For Dividend
StockIssuedForDividend
31545 shares
CY2019Q2 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.004 pure
CY2019Q2 sar Stock Based Share Price
StockBasedSharePrice
22.65
CY2019Q2 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2019Q1 us-gaap Dividends Cash
DividendsCash
3500000 usd
CY2019Q1 sar Stock Issued For Dividend
StockIssuedForDividend
31240 shares
CY2019Q1 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.004 pure
CY2019Q1 sar Stock Based Share Price
StockBasedSharePrice
21.36
CY2019Q1 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2019Q1 us-gaap Dividends Cash
DividendsCash
3400000 usd
CY2019Q1 sar Stock Issued For Dividend
StockIssuedForDividend
30796 shares
CY2019Q1 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.004 pure
CY2019Q1 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2019Q1 sar Stock Based Share Price
StockBasedSharePrice
18.88
CY2018Q3 us-gaap Dividends Cash
DividendsCash
3300000 usd
CY2018Q3 sar Stock Issued For Dividend
StockIssuedForDividend
25862 shares
CY2018Q3 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.003 pure
CY2018Q3 sar Stock Based Share Price
StockBasedSharePrice
22.35
CY2018Q3 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2018Q2 us-gaap Dividends Cash
DividendsCash
2700000 usd
CY2018Q2 sar Stock Issued For Dividend
StockIssuedForDividend
21562 shares
CY2018Q2 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.003 pure
CY2018Q2 sar Stock Based Share Price
StockBasedSharePrice
23.72
CY2018Q2 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2018Q1 us-gaap Dividends Cash
DividendsCash
2600000 usd
CY2018Q1 sar Stock Issued For Dividend
StockIssuedForDividend
25354 shares
CY2018Q1 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.004 pure
CY2018Q1 sar Stock Based Share Price
StockBasedSharePrice
19.91
CY2018Q1 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2017Q4 us-gaap Dividends Cash
DividendsCash
2500000 usd
CY2017Q4 sar Stock Issued For Dividend
StockIssuedForDividend
25435 shares
CY2017Q4 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.004 pure
CY2017Q4 sar Stock Based Share Price
StockBasedSharePrice
21.14
CY2017Q4 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2017Q3 us-gaap Dividends Cash
DividendsCash
2200000 usd
CY2017Q3 sar Stock Issued For Dividend
StockIssuedForDividend
33551 shares
CY2017Q3 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.006 pure
CY2017Q3 sar Stock Based Share Price
StockBasedSharePrice
20.19
CY2017Q3 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2017Q2 us-gaap Dividends Cash
DividendsCash
2300000 usd
CY2017Q2 sar Stock Issued For Dividend
StockIssuedForDividend
26222 shares
CY2017Q2 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.004 pure
CY2017Q2 sar Stock Based Share Price
StockBasedSharePrice
20.04
CY2017Q2 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2017Q1 us-gaap Dividends Cash
DividendsCash
2000000 usd
CY2017Q1 sar Stock Issued For Dividend
StockIssuedForDividend
29096 shares
CY2017Q1 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.005 pure
CY2017Q1 sar Stock Based Share Price
StockBasedSharePrice
21.38
CY2017Q1 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2017Q1 us-gaap Dividends Cash
DividendsCash
1600000 usd
CY2017Q1 sar Stock Issued For Dividend
StockIssuedForDividend
50453 shares
CY2017Q1 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.009 pure
CY2017Q1 sar Stock Based Share Price
StockBasedSharePrice
20.25
CY2017Q1 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2016Q4 us-gaap Dividends Cash
DividendsCash
1500000 usd
CY2016Q4 sar Stock Issued For Dividend
StockIssuedForDividend
58548 shares
CY2016Q4 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.01 pure
CY2016Q4 sar Stock Based Share Price
StockBasedSharePrice
17.12
CY2016Q4 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2016Q3 us-gaap Dividends Cash
DividendsCash
700000 usd
CY2016Q3 sar Stock Issued For Dividend
StockIssuedForDividend
24786 shares
CY2016Q3 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.004 pure
CY2016Q3 sar Stock Based Share Price
StockBasedSharePrice
17.06
CY2016Q3 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2016Q3 us-gaap Dividends Cash
DividendsCash
1500000 usd
CY2016Q3 sar Stock Issued For Dividend
StockIssuedForDividend
58167 shares
CY2016Q3 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.01 pure
CY2016Q3 sar Stock Based Share Price
StockBasedSharePrice
16.32
CY2016Q3 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2016Q2 us-gaap Dividends Cash
DividendsCash
1500000 usd
CY2016Q2 sar Stock Issued For Dividend
StockIssuedForDividend
56728 shares
CY2016Q2 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.01 pure
CY2016Q2 sar Stock Based Share Price
StockBasedSharePrice
15.43
CY2016Q2 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2016Q1 us-gaap Dividends Cash
DividendsCash
1400000 usd
CY2016Q1 sar Stock Issued For Dividend
StockIssuedForDividend
66765 shares
CY2016Q1 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.012 pure
CY2016Q1 sar Stock Based Share Price
StockBasedSharePrice
13.11
CY2016Q1 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2015Q4 us-gaap Dividends Cash
DividendsCash
1100000 usd
CY2015Q4 sar Stock Issued For Dividend
StockIssuedForDividend
61029 shares
CY2015Q4 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.011 pure
CY2015Q4 sar Stock Based Share Price
StockBasedSharePrice
14.53
CY2015Q4 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2015Q3 us-gaap Dividends Cash
DividendsCash
1100000 usd
CY2015Q3 sar Stock Issued For Dividend
StockIssuedForDividend
47861 shares
CY2015Q3 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.009 pure
CY2015Q3 sar Stock Based Share Price
StockBasedSharePrice
15.28
CY2015Q3 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2015Q2 us-gaap Dividends Cash
DividendsCash
3400000 usd
CY2015Q2 sar Stock Issued For Dividend
StockIssuedForDividend
126230 shares
CY2015Q2 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.023 pure
CY2015Q2 sar Stock Based Share Price
StockBasedSharePrice
16.47
CY2015Q2 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2015Q2 us-gaap Dividends Cash
DividendsCash
900000 usd
CY2015Q2 sar Stock Issued For Dividend
StockIssuedForDividend
33766 shares
CY2015Q2 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.006 pure
CY2015Q2 sar Stock Based Share Price
StockBasedSharePrice
16.78
CY2015Q2 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2015Q1 us-gaap Dividends Cash
DividendsCash
800000 usd
CY2015Q1 sar Stock Issued For Dividend
StockIssuedForDividend
26858 shares
CY2015Q1 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.005 pure
CY2015Q1 sar Stock Based Share Price
StockBasedSharePrice
14.97
CY2015Q1 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2014Q4 us-gaap Dividends Cash
DividendsCash
600000 usd
CY2014Q4 sar Stock Issued For Dividend
StockIssuedForDividend
22283 shares
CY2014Q4 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.004 pure
CY2014Q4 sar Stock Based Share Price
StockBasedSharePrice
14.37
CY2014Q4 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2013Q4 us-gaap Dividends Cash
DividendsCash
2500000 usd
CY2013Q4 sar Stock Issued For Dividend
StockIssuedForDividend
649500 shares
CY2013Q4 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.137 pure
CY2013Q4 sar Aggregate Dividend Amount Percentage
AggregateDividendAmountPercentage
0.20 pure
CY2013Q4 sar Stock Based Share Price
StockBasedSharePrice
15.439
CY2012Q4 us-gaap Dividends Cash
DividendsCash
3300000 usd
CY2012Q4 sar Stock Issued For Dividend
StockIssuedForDividend
853455 shares
CY2012Q4 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.22 pure
CY2012Q4 sar Aggregate Dividend Amount Percentage
AggregateDividendAmountPercentage
0.20 pure
CY2012Q4 sar Stock Based Share Price
StockBasedSharePrice
15.444
CY2011Q4 us-gaap Dividends Cash
DividendsCash
2000000 usd
CY2011Q4 sar Stock Issued For Dividend
StockIssuedForDividend
599584 shares
CY2011Q4 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.18 pure
CY2011Q4 sar Aggregate Dividend Amount Percentage
AggregateDividendAmountPercentage
0.20 pure
CY2011Q4 sar Stock Based Share Price
StockBasedSharePrice
13.117067
CY2010Q4 us-gaap Dividends Cash
DividendsCash
1200000 usd
CY2010Q4 sar Stock Issued For Dividend
StockIssuedForDividend
596235 shares
CY2010Q4 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.22 pure
CY2010Q4 sar Aggregate Dividend Amount Percentage
AggregateDividendAmountPercentage
0.10 pure
CY2010Q4 sar Stock Based Share Price
StockBasedSharePrice
17.8049
CY2009Q4 us-gaap Dividends Cash
DividendsCash
2100000 usd
CY2009Q4 sar Stock Issued For Dividend
StockIssuedForDividend
864872 shares
CY2009Q4 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
1.04 pure
CY2009Q4 sar Aggregate Dividend Amount Percentage
AggregateDividendAmountPercentage
0.137 pure
CY2009Q4 sar Stock Based Share Price
StockBasedSharePrice
1.5099
CY2023Q2 us-gaap Dividends Cash
DividendsCash
7600000 usd
CY2023Q2 sar Stock Issued For Dividend
StockIssuedForDividend
29627 shares
CY2023Q2 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.002 pure
CY2023Q2 sar Stock Based Share Price
StockBasedSharePrice
25.29
CY2023Q2 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2023Q3 us-gaap Dividends Cash
DividendsCash
8400000 usd
CY2023Q3 sar Stock Issued For Dividend
StockIssuedForDividend
35196 shares
CY2023Q3 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.003 pure
CY2023Q3 sar Stock Based Share Price
StockBasedSharePrice
24.41
CY2023Q3 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2023Q4 us-gaap Dividends Cash
DividendsCash
8900000 usd
CY2023Q4 sar Stock Issued For Dividend
StockIssuedForDividend
37394 shares
CY2023Q4 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.003 pure
CY2023Q4 sar Stock Based Share Price
StockBasedSharePrice
24.47
CY2023Q4 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2024Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
2.86
CY2024Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
37409000 usd
CY2023Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
2.44
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
29077000 usd
CY2022Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
1.92
CY2022Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
22032000 usd
CY2021Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
1.23
CY2021Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
13747000 usd
CY2020Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
2.21
CY2020Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
20097000 usd
CY2023Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
29.18
CY2022Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
29.33
CY2021Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
27.25
CY2020Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
27.13
CY2019Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
23.62
CY2024 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
4.49
CY2023 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
2.94
CY2022 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
1.74
CY2021 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
2.07
CY2020 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
1.59
CY2024 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-3.77
CY2023 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.75
CY2022 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
2.46
CY2021 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.74
CY2020 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
4.56
CY2024 sar Investment Company Realized Losses On Extinguishment Of Debt
InvestmentCompanyRealizedLossesOnExtinguishmentOfDebt
-0.01
CY2023 sar Investment Company Realized Losses On Extinguishment Of Debt
InvestmentCompanyRealizedLossesOnExtinguishmentOfDebt
-0.13
CY2022 sar Investment Company Realized Losses On Extinguishment Of Debt
InvestmentCompanyRealizedLossesOnExtinguishmentOfDebt
-0.21
CY2021 sar Investment Company Realized Losses On Extinguishment Of Debt
InvestmentCompanyRealizedLossesOnExtinguishmentOfDebt
-0.01
CY2020 sar Investment Company Realized Losses On Extinguishment Of Debt
InvestmentCompanyRealizedLossesOnExtinguishmentOfDebt
-0.17
CY2024 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
0.71
CY2023 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
2.06
CY2022 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
3.99
CY2021 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
1.32
CY2020 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
5.98
CY2024 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
2.82
CY2023 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
2.28
CY2022 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
1.93
CY2021 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
1.23
CY2020 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
2.21
CY2024 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
2.82
CY2023 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
2.28
CY2022 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
1.93
CY2021 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
1.23
CY2020 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
2.21
CY2024 sar Investment Company Issuance Of Common Stock Above Net Asset Value
InvestmentCompanyIssuanceOfCommonStockAboveNetAssetValue
0.4
CY2023 sar Investment Company Issuance Of Common Stock Above Net Asset Value
InvestmentCompanyIssuanceOfCommonStockAboveNetAssetValue
2.28
CY2022 sar Investment Company Issuance Of Common Stock Above Net Asset Value
InvestmentCompanyIssuanceOfCommonStockAboveNetAssetValue
1.93
CY2021 sar Investment Company Issuance Of Common Stock Above Net Asset Value
InvestmentCompanyIssuanceOfCommonStockAboveNetAssetValue
1.23
CY2020 sar Investment Company Issuance Of Common Stock Above Net Asset Value
InvestmentCompanyIssuanceOfCommonStockAboveNetAssetValue
2.21
CY2024 us-gaap Investment Company Issuance Of Shares Per Share
InvestmentCompanyIssuanceOfSharesPerShare
0.48
CY2024 sar Repurchases Of Common Stock
RepurchasesOfCommonStock
0.03
CY2023 sar Repurchases Of Common Stock
RepurchasesOfCommonStock
0.17
CY2022 sar Repurchases Of Common Stock
RepurchasesOfCommonStock
0.01
CY2021 sar Repurchases Of Common Stock
RepurchasesOfCommonStock
0.13
CY2024 sar Investment Company Dilution Per Share
InvestmentCompanyDilutionPerShare
-0.06
CY2023 sar Investment Company Dilution Per Share
InvestmentCompanyDilutionPerShare
-0.1
CY2021 sar Investment Company Dilution Per Share
InvestmentCompanyDilutionPerShare
-0.1
CY2020 sar Investment Company Dilution Per Share
InvestmentCompanyDilutionPerShare
-0.26
CY2024Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
27.12
CY2023Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
29.18
CY2022Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
29.33
CY2021Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
27.25
CY2020Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
27.13
CY2024Q1 us-gaap Assets Net
AssetsNet
370224108 usd
CY2023Q1 us-gaap Assets Net
AssetsNet
346958042 usd
CY2022Q1 us-gaap Assets Net
AssetsNet
355780523 usd
CY2021Q1 us-gaap Assets Net
AssetsNet
304185770 usd
CY2020Q1 us-gaap Assets Net
AssetsNet
304286853 usd
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13653476 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11890500 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12131350 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11161416 shares
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11217545 shares
CY2024Q1 us-gaap Investment Company Market Value Per Share
InvestmentCompanyMarketValuePerShare
23.61
CY2023Q1 us-gaap Investment Company Market Value Per Share
InvestmentCompanyMarketValuePerShare
27.55
CY2022Q1 us-gaap Investment Company Market Value Per Share
InvestmentCompanyMarketValuePerShare
27.47
CY2021Q1 us-gaap Investment Company Market Value Per Share
InvestmentCompanyMarketValuePerShare
23.08
CY2020Q1 us-gaap Investment Company Market Value Per Share
InvestmentCompanyMarketValuePerShare
22.91
CY2024 sar Investment Company Total Returns Based On Market Value
InvestmentCompanyTotalReturnsBasedOnMarketValue
-0.0392 pure
CY2023 sar Investment Company Total Returns Based On Market Value
InvestmentCompanyTotalReturnsBasedOnMarketValue
0.1035 pure
CY2022 sar Investment Company Total Returns Based On Market Value
InvestmentCompanyTotalReturnsBasedOnMarketValue
0.2819 pure
CY2021 sar Investment Company Total Returns Based On Market Value
InvestmentCompanyTotalReturnsBasedOnMarketValue
0.0763 pure
CY2020 sar Investment Company Total Returns Based On Market Value
InvestmentCompanyTotalReturnsBasedOnMarketValue
0.0928 pure
CY2024 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.042 pure
CY2023 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.0946 pure
CY2022 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.1588 pure
CY2021 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.0731 pure
CY2020 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.2622 pure
CY2024 sar Investments Owned Percent Of Net Assets
InvestmentsOwnedPercentOfNetAssets
0.1601 pure
CY2023 sar Investments Owned Percent Of Net Assets
InvestmentsOwnedPercentOfNetAssets
0.1023 pure
CY2022 sar Investments Owned Percent Of Net Assets
InvestmentsOwnedPercentOfNetAssets
0.0605 pure
CY2021 sar Investments Owned Percent Of Net Assets
InvestmentsOwnedPercentOfNetAssets
0.0777 pure
CY2020 sar Investments Owned Percent Of Net Assets
InvestmentsOwnedPercentOfNetAssets
0.0631 pure
CY2024 sar Ratio Of Loss On Extinguishment Of Debt To Average Net Assets
RatioOfLossOnExtinguishmentOfDebtToAverageNetAssets
0.0003 pure
CY2023 sar Ratio Of Loss On Extinguishment Of Debt To Average Net Assets
RatioOfLossOnExtinguishmentOfDebtToAverageNetAssets
0.0046 pure
CY2022 sar Ratio Of Loss On Extinguishment Of Debt To Average Net Assets
RatioOfLossOnExtinguishmentOfDebtToAverageNetAssets
0.0074 pure
CY2021 sar Ratio Of Loss On Extinguishment Of Debt To Average Net Assets
RatioOfLossOnExtinguishmentOfDebtToAverageNetAssets
0.0004 pure
CY2020 sar Ratio Of Loss On Extinguishment Of Debt To Average Net Assets
RatioOfLossOnExtinguishmentOfDebtToAverageNetAssets
0.0067 pure
CY2024 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0859 pure
CY2023 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0771 pure
CY2022 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0648 pure
CY2021 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.069 pure
CY2020 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.061 pure
CY2024 sar Investment Company Expenses Ratio Including Incentive Fee
InvestmentCompanyExpensesRatioIncludingIncentiveFee
0.0226 pure
CY2023 sar Investment Company Expenses Ratio Including Incentive Fee
InvestmentCompanyExpensesRatioIncludingIncentiveFee
0.0147 pure
CY2022 sar Investment Company Expenses Ratio Including Incentive Fee
InvestmentCompanyExpensesRatioIncludingIncentiveFee
0.0358 pure
CY2021 sar Investment Company Expenses Ratio Including Incentive Fee
InvestmentCompanyExpensesRatioIncludingIncentiveFee
0.0165 pure
CY2020 sar Investment Company Expenses Ratio Including Incentive Fee
InvestmentCompanyExpensesRatioIncludingIncentiveFee
0.0601 pure
CY2024 sar Investment Company Interest And Debt Financing Expenses To Average Net Assets
InvestmentCompanyInterestAndDebtFinancingExpensesToAverageNetAssets
0.1384 pure
CY2023 sar Investment Company Interest And Debt Financing Expenses To Average Net Assets
InvestmentCompanyInterestAndDebtFinancingExpensesToAverageNetAssets
0.0973 pure
CY2022 sar Investment Company Interest And Debt Financing Expenses To Average Net Assets
InvestmentCompanyInterestAndDebtFinancingExpensesToAverageNetAssets
0.0603 pure
CY2021 sar Investment Company Interest And Debt Financing Expenses To Average Net Assets
InvestmentCompanyInterestAndDebtFinancingExpensesToAverageNetAssets
0.0456 pure
CY2020 sar Investment Company Interest And Debt Financing Expenses To Average Net Assets
InvestmentCompanyInterestAndDebtFinancingExpensesToAverageNetAssets
0.0623 pure
CY2024 sar Investment Company Total Expense To Average Net Assets
InvestmentCompanyTotalExpenseToAverageNetAssets
0.247 pure
CY2023 sar Investment Company Total Expense To Average Net Assets
InvestmentCompanyTotalExpenseToAverageNetAssets
0.1891 pure
CY2022 sar Investment Company Total Expense To Average Net Assets
InvestmentCompanyTotalExpenseToAverageNetAssets
0.1609 pure
CY2021 sar Investment Company Total Expense To Average Net Assets
InvestmentCompanyTotalExpenseToAverageNetAssets
0.1311 pure
CY2020 sar Investment Company Total Expense To Average Net Assets
InvestmentCompanyTotalExpenseToAverageNetAssets
0.1834 pure
CY2024 sar Portfolio Turnover Rate
PortfolioTurnoverRate
0.028 pure
CY2023 sar Portfolio Turnover Rate
PortfolioTurnoverRate
0.2405 pure
CY2022 sar Portfolio Turnover Rate
PortfolioTurnoverRate
0.3359 pure
CY2021 sar Portfolio Turnover Rate
PortfolioTurnoverRate
0.2526 pure
CY2020 sar Portfolio Turnover Rate
PortfolioTurnoverRate
0.3682 pure
CY2024 sar Asset Coverage Ratio Per Units
AssetCoverageRatioPerUnits
1610 usd
CY2023 sar Asset Coverage Ratio Per Units
AssetCoverageRatioPerUnits
1659 usd
CY2022 sar Asset Coverage Ratio Per Units
AssetCoverageRatioPerUnits
2092 usd
CY2021 sar Asset Coverage Ratio Per Units
AssetCoverageRatioPerUnits
3471 usd
CY2020 sar Asset Coverage Ratio Per Units
AssetCoverageRatioPerUnits
6071 usd
CY2024 sar Indebtedness Amount
IndebtednessAmount
1000 usd
CY2024 us-gaap Line Of Credit Facility Description
LineOfCreditFacilityDescription
The Revolving Credit Facility, SBA Debentures, 8.75 Notes Payable 2025, 7.75% Notes Payable 2025, 4.375% Notes Payable 2026, 4.35% Notes Payable 2026, 7.00% Notes Payable 2025 and 6.25% Notes Payable 2027 are not registered for public trading.
CY2020Q1 us-gaap Debt Instrument Redemption Description
DebtInstrumentRedemptionDescription
On December 21, 2019 and February 7, 2020, the Company redeemed $50.0 million and $24.5 million, respectively, in aggregate principal amount of the $74.5 million in aggregate principal amount of issued and outstanding 2023 Notes and are no longer listed on the NYSE.
CY2019Q4 us-gaap Debt Instrument Redemption Description
DebtInstrumentRedemptionDescription
On December 21, 2019 and February 7, 2020, the Company redeemed $50.0 million and $24.5 million, respectively, in aggregate principal amount of the $74.5 million in aggregate principal amount of issued and outstanding 2023 Notes and are no longer listed on the NYSE.
CY2021Q3 us-gaap Debt Instrument Redemption Description
DebtInstrumentRedemptionDescription
On August 31, 2021, the Company redeemed $60.0 million in aggregate principal amount of the issued and outstanding 6.25% 2025 Notes and, as a result of the full redemption, the 6.25% 2025 Notes are no longer listed on the NYSE.
CY2022Q3 us-gaap Debt Instrument Redemption Description
DebtInstrumentRedemptionDescription
On July 14, 2022, the Company redeemed $43.1 million in aggregate principal amount of the $43.1 million in aggregate principal amount of issued and outstanding 7.25% 2025 Notes and are no longer listed on the NYSE.
CY2024Q1 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
50000000 usd
CY2024Q1 sar Line Of Credit Facility Minimum Borrowing Capacity
LineOfCreditFacilityMinimumBorrowingCapacity
12500000 usd
CY2024Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
25000000 usd
CY2024Q1 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.50 pure
CY2024 us-gaap Line Of Credit Facility Unused Capacity Commitment Fee Percentage
LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
0.005 pure
CY2024Q1 sar Directors Fees Payable
DirectorsFeesPayable
usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022 sar Payment In Kind Interest Income On Affiliate Investments
PaymentInKindInterestIncomeOnAffiliateInvestments
usd
CY2024 sar Dividend Income On Affiliate Investments
DividendIncomeOnAffiliateInvestments
usd
CY2023 sar Dividend Income On Control Investments
DividendIncomeOnControlInvestments
usd
CY2022 sar Dividend Income On Control Investments
DividendIncomeOnControlInvestments
usd
CY2024 sar Affiliate Investments
AffiliateInvestments
usd
CY2023 sar Affiliate Investments
AffiliateInvestments
usd
CY2024 sar Realized Gain Loss From Control Investments
RealizedGainLossFromControlInvestments
usd
CY2023 sar Realized Gain Loss From Control Investments
RealizedGainLossFromControlInvestments
usd
CY2024 sar Income Tax Provision Benefit From Realized Gain Loss On Investments
IncomeTaxProvisionBenefitFromRealizedGainLossOnInvestments
usd
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.71
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.06
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.99
CY2022 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
11456631 shares
CY2023 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
11963533 shares
CY2024 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
12670939 shares
CY2024 sar Income Tax Provision Benefit From Realized Gain Loss On Investments
IncomeTaxProvisionBenefitFromRealizedGainLossOnInvestments
usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2023 sar Stock Issued During Period Capital Contribution From Manager
StockIssuedDuringPeriodCapitalContributionFromManager
usd
CY2022 sar Stock Issued During Period Capital Contribution From Manager
StockIssuedDuringPeriodCapitalContributionFromManager
usd
CY2023 sar Stock Issued During Period Value Offering Cost
StockIssuedDuringPeriodValueOfferingCost
usd
CY2024 us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
usd
CY2024 sar Increase Decrease In Current Tax Payable
IncreaseDecreaseInCurrentTaxPayable
usd
CY2024 sar Increase Decrease In Excise Tax Payable
IncreaseDecreaseInExciseTaxPayable
usd
CY2024 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
CY2024 sar Discount On Debt Issuance On Notes
DiscountOnDebtIssuanceOnNotes
usd
CY2022 sar Discount On Debt Issuance On Notes
DiscountOnDebtIssuanceOnNotes
usd
CY2024 sar Discount On Debt Issuance Notes Two Thousand Twenty Five
DiscountOnDebtIssuanceNotesTwoThousandTwentyFive
usd
CY2022 sar Discount On Debt Issuance Notes Two Thousand Twenty Five
DiscountOnDebtIssuanceNotesTwoThousandTwentyFive
usd
CY2024 sar Premium On Debt Issuance
PremiumOnDebtIssuance
usd
CY2023 sar Premium On Debt Issuance
PremiumOnDebtIssuance
usd
CY2024 sar Discount On Debt Issuance Two Thousand Twenty Seven
DiscountOnDebtIssuanceTwoThousandTwentySeven
usd
CY2023 sar Discount On Debt Issuance Two Thousand Twenty Seven
DiscountOnDebtIssuanceTwoThousandTwentySeven
usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2023 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
usd
CY2022 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
usd
CY2023 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
usd
CY2024Q1 us-gaap Investment Company Distributable Earnings Loss Accumulated Long Term Capital Gain Loss
InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss
usd
CY2023Q1 us-gaap Investment Company Distributable Earnings Loss Accumulated Long Term Capital Gain Loss
InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss
usd
CY2022Q1 us-gaap Investment Company Distributable Earnings Loss Accumulated Long Term Capital Gain Loss
InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss
usd
CY2024 sar Post October Loss Deferred
PostOctoberLossDeferred
usd
CY2023 sar Post October Loss Deferred
PostOctoberLossDeferred
usd
CY2024 sar Undistributed Long Term Gain
UndistributedLongTermGain
usd
CY2023 sar Undistributed Long Term Gain
UndistributedLongTermGain
usd
CY2024 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2024 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
CY2024 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
usd
CY2024 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
usd
CY2023Q1 sar Tax Reclassification Of Stockholders Equity
TaxReclassificationOfStockholdersEquity
usd
CY2023 us-gaap Investment Company Issuance Of Shares Per Share
InvestmentCompanyIssuanceOfSharesPerShare
CY2022 us-gaap Investment Company Issuance Of Shares Per Share
InvestmentCompanyIssuanceOfSharesPerShare
CY2021 us-gaap Investment Company Issuance Of Shares Per Share
InvestmentCompanyIssuanceOfSharesPerShare
CY2020 us-gaap Investment Company Issuance Of Shares Per Share
InvestmentCompanyIssuanceOfSharesPerShare
CY2020 sar Repurchases Of Common Stock
RepurchasesOfCommonStock
CY2022 sar Investment Company Dilution Per Share
InvestmentCompanyDilutionPerShare
CY2024 sar Average Market Value Per Unit Of Revolving Credit Facility
AverageMarketValuePerUnitOfRevolvingCreditFacility
CY2023 sar Average Market Value Per Unit Of Revolving Credit Facility
AverageMarketValuePerUnitOfRevolvingCreditFacility
CY2022 sar Average Market Value Per Unit Of Revolving Credit Facility
AverageMarketValuePerUnitOfRevolvingCreditFacility
CY2021 sar Average Market Value Per Unit Of Revolving Credit Facility
AverageMarketValuePerUnitOfRevolvingCreditFacility
CY2020 sar Average Market Value Per Unit Of Revolving Credit Facility
AverageMarketValuePerUnitOfRevolvingCreditFacility
CY2024 sar Average Market Value Per Unit Of Small Business Administration Debentures Payable
AverageMarketValuePerUnitOfSmallBusinessAdministrationDebenturesPayable
CY2023 sar Average Market Value Per Unit Of Small Business Administration Debentures Payable
AverageMarketValuePerUnitOfSmallBusinessAdministrationDebenturesPayable
CY2022 sar Average Market Value Per Unit Of Small Business Administration Debentures Payable
AverageMarketValuePerUnitOfSmallBusinessAdministrationDebenturesPayable
CY2021 sar Average Market Value Per Unit Of Small Business Administration Debentures Payable
AverageMarketValuePerUnitOfSmallBusinessAdministrationDebenturesPayable
CY2020 sar Average Market Value Per Unit Of Small Business Administration Debentures Payable
AverageMarketValuePerUnitOfSmallBusinessAdministrationDebenturesPayable
CY2024 dei Amendment Flag
AmendmentFlag
false
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-28
CY2024 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001377936

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
sar-20240229_cal.xml Edgar Link unprocessable
0001213900-24-040080-index-headers.html Edgar Link pending
0001213900-24-040080-index.html Edgar Link pending
0001213900-24-040080.txt Edgar Link pending
0001213900-24-040080-xbrl.zip Edgar Link pending
ea0202624-10k_saratoga.htm Edgar Link pending
ea020262401ex19_saratoga.htm Edgar Link pending
ea020262401ex21_saratoga.htm Edgar Link pending
ea020262401ex23-1_saratoga.htm Edgar Link pending
ea020262401ex23-2_saratoga.htm Edgar Link pending
ea0202624-10k_saratoga_htm.xml Edgar Link completed
ea020262401ex31-1_saratoga.htm Edgar Link pending
ea020262401ex31-2_saratoga.htm Edgar Link pending
ea020262401ex32-1_saratoga.htm Edgar Link pending
ea020262401ex32-2_saratoga.htm Edgar Link pending
ea020262401ex97-1_saratoga.htm Edgar Link pending
ex23-2_001.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
fin_001.jpg Edgar Link pending
image_001.jpg Edgar Link pending
image_002.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sar-20240229.xsd Edgar Link pending
Show.js Edgar Link pending
sar-20240229_lab.xml Edgar Link unprocessable
sar-20240229_pre.xml Edgar Link unprocessable
sar-20240229_def.xml Edgar Link unprocessable